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Summary 
This combined research thesis, submitted to the University of Birmingham, consists of two 
projects. The first project addressed the neurotoxic effects by three of the most widely used 
flame retardants – hexabromocylododecane, tetrabromobisphenol-A and decabromodiphenyl 
ether in SH-SY5Y human neuroblastoma cells. The results demonstrated high toxicity 
potential in all three compounds even at low concentrations. Moreover, all compounds caused 
DNA single-strand breaks at non-cytotoxic concentrations. HBCD proved to be more potent 
than other two compounds tested. Therefore, it can be concluded that all three compounds are 
potentially neurotoxic and what more, genotoxic in human cells in-vitro. 
The second project attempted to finish the genome of multidrug-resistant Elizabethkingia 
meningoseptica 501 and start finishing the genome of a new Pseudomonas aeruginosa ST395 
strain, employing whole-genome Nextera XT and Mate Pair sequencing (Illumina). 
Optimization of Nextera XT for organisms with different GC content was also carried out in 
the study using 3 species – Escherichia coli (Medium GC), Pseudomonas aeruginosa (high 
GC) and Elizabethkingia meningoseptica (low GC). Finally, using PCR and Sanger 
sequencing, the genome of E. meningoseptica was almost completed, obtaining 4 gapped 
fragments of the genome, what makes HTS (high-throughput sequencing) a very powerful 
scientific tool. 
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Abstract 
Brominated flame retardants (BFR) are substances, added to various consumer products to 
prevent their inflammation. They are widespread pollutants in the environment and ubiquitous 
contaminants in humans. So far only few studies assessed the neurotoxicity of brominated 
flame retardants, therefore in this report neurotoxic effects by three of the most widely used 
flame retardants – hexabromocylododecane (HBCD) tetrabromobisphenol-A (TBBP-A) and 
decabromodiphenyl ether (BDE-209) in SH-SY5Y human neuroblastoma cells were 
investigated. The results demonstrated high toxicity potential in all three compounds even at 
low concentrations (with LC50 values between 2.5 and 5 µM, 15 and 20 µM, 30 and 60 µM 
for HBCD, TBBP-A and BDE-209, respectively). Concentration-dependent increases in 
reactive oxygen species (ROS) were observed in cells treated with TBBP-A, but not in cells 
treated with HBCD. There was also a depletion of neuronal antioxidant – glutathione (GSH) 
following treatment of cells with HBCD, but no response with TBBP-A. In contrast, BDE-
209 caused only minor changes in ROS and GSH levels. Following treatment with HBCD, 
TBBP-A and BDE-209 there was increased annexin V staining, indicative of apoptosis. 
HBCD treated cells also showed increased PI labeling (necrosis indicator) and autophagic 
puncta in GFP transfected cells. Furthermore, DNA strand breaks were also measured. It has 
been known that BDE-209 causes DNA strand breaks in neuronal cells, but there have been 
no studies investigating the ability of HBCD and TBBP-A to induce DNA damage. In the 
current study, all compounds caused DNA single-strand breaks at non-cytotoxic 
concentrations. HBCD proved to be more potent than other two compounds tested. In 
summary, it can be concluded that all three compounds are potentially neurotoxic and what 
more, genotoxic in human cells in-vitro. 
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1. Introduction 
 
1.1. Brominated flame retardants 
In the modern world production of electronical appliances, materials for building construction 
and domestic use is rising every year and along with those the demand for Brominated flame 
retardants (BFR) is increasing (Alaee et al., 2003). While in 1990 only 145 000 metric tons of 
BFRs were produced worldwide (Pettigrew, 1994), by 2000 the production increased almost 2 
fold making 310 000 tones (BSEF, 2000), and in 2008 the number reached 410 000 tons (Fink 
et al., 2008; Chart 1.1). 
 
Chart 1.1. BFR production form 1990 – 2008, metric tons. 
 
Brominated flame retardants are substances that lower the risk of ignition in electronics, 
furnishing and construction materials. They are chemicals with long degradation period 
widely spread in the environment, and as a result BFRs are referred as persistent organic 
pollutants (POPs) (Al-Mousa & Michelangeli, 2012). Brominated flame retardants are found 
not only close to the production sources, but also in regions distant from the source as they 
may spread via air or water (Fonnum & Mariussen, 2009). These pollutants can be 
bioaccamulated by animals and humans, causing neurological disorders and influencing 
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learning, memory and motor functions (Al-Mousa & Michelangeli, 2012). BFR influence on 
nervous system is of particular concern as neuronal cells are very sensitive to toxicity 
especially in early development period (Weiss 2000). 
At the present time there are more than 175 compounds in the flame retardant (FR) group. 
FRs are represented by 4 main families: inorganic (50% of all FRs per year) such as 
aluminium trihydroxide and red phosphorus; halogenated organic (25% of all FRs per year) 
chlorine and bromine (BFR) based; organophosphorus (20% of all FRs per year), mainly 
phosphate esters and the rarest - nitrogen-based (>5% of all FRs per year) (EHC-192, 1997).  
According to the way BFRs create polymers they are classified as brominated monomers, 
reactive or additive. From brominated monomers, for instance, brominated styrene or 
butadiene complex compounds can be created. Reactive BFRs, for example, 
tetrabromobisphenol A (TBBP-A) are added to polymer products and are embedded into 
them. Whereas additive flame retardants such as polybrominated diphenyl ethers (PBDEs) 
and hexabromocylododecane (HBCD) are mixed with the manufactured product without 
chemical bonding and they have higher probability to leach into the environment (Hutzinger 
& Thoma, 1987). 
 
1.2. HBCD 
Hexabromocyclododecanes (HBCDs) are brominated cycloaliphatic additive hydrocarbons 
used to diminish flammability in construction materials, upholstery textiles and electronical 
devices. At the present moment HBCDs are referred as persistent, toxic and ubiquitous 
contaminants since they are common in the environment and bioaccumulative in humans 
(Covaci et al., 2006). 
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1.2.1. Chemical and physical characteristics 
The compound 1,2,5,6,9,10-hexabromocyclododecane (HBCD, C12H18Br6) is a white 
crystalline powder, with 74.7% bromine (Figure 1.1. a). It is thermally rearranged at 
temperatures above 160 °C, what leads to formation of 3 specific diastereoisomers – α, β and 
γ. The most common γ isomer makes up to 70% of the final HBCD mixture, while α and β are 
represented only by 10 and 6% (the rest are additives; Marvin et al., 2011). The difference in 
isomer structure may cause various polarities, dipole moments and water solubility. Solubility 
for γ, α and β isomers was measured by Hunziker et al. accounting 48.8, 14.7 and 2.1 íg/L, 
respectively (Hunziker et al 2004). These dissimilarities may lead to different biological 
uptake, metabolism and could explain diverse environmental behaviour (de Wit, 2002; Law et 
al., 2003). 
All previous studies proved that diastereoisomer γ dominates only in technical HBCD and 
along with trophic level shift (food chain development from primary producers to predators) 
accumulation of isomer α is increasing and becomes greater than γ and β (Law et al., 2006; 
Law et al., 2007; Covaci et al., 2006; Tomy et al., 2008). This shift through the food chain is 
possibly a consequence of varied water solubility, bioavailability, uptake and depuration 
kinetics (including biotransformation) and better in-vivo bioisomerization of α-HBCD 
compared with 2 other isomers (Covaci et al., 2006; Wu et al., 2010). 
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Figure 1.1. General structure of a) HBCD, b) TBBP-A, c) BDE-209 (Created using ChemDoodle 
software). 
 
1.2.2. Occurrence and exposure 
The production of HBCD started in 1960s and today it is one of the most commonly used 
brominated flame retardant. In 2001 HBCD was taking the 3
rd
 place in annual production of 
all BFRs (Chart 1.2) in the world - 16 700 t, after only tetrabromobisphenol-A (>130 000 t) 
and decabromodiphenyl ether (56 100 t). EU consumption of the compound in 2005 was 11 
000 t (Janak et al., 2005), what is almost half of produced HBCD. Generally HBCD is used in 
construction industry where is included approximately at <3% by weight into polystyrene 
foam materials. It is also employed in production of upholstered furniture, transport interior 
textiles and cushions, electric and electronic devices (Marvin et al., 2011). 
HBCDs were first observed in 1998 by Sellstrom et al. in fish and sediment samples from the 
river Viskan in Sweden and, since then, widely found in the environment and biota. The 
compound was detected in air samples of northern Sweden and Finland and in various animal 
samples including fish, seals, polar bears, glaucous gulls, and peregrine falcons from Eastern 
Greenland and Svalbard (de Wit et al., 2004; Verreault et al., 2005; Vorkamp et al., 2005; 
Jenssen et al., 2004). From those studies it can be concluded that HBCDs undergo long-range 
transport. 
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The most frequent HBCD exposure sources for humans are food, dust, air and consumer 
products (Covaci et al., 2006; Harrad et al., 2010; Goosey et al., 2010). There are two major 
pathways of compound exposure – dermal and oral as a result of inhalation of vapour and 
particles (ECRA, 2008). The main risk group is firstly people working at plants producing 
EPS (expanded polysterene) with HBCD; they are exposed to HBCD mostly via direct dermal 
exposure or inhalation. Measured levels of the pollutant in blood serum of industrial workers 
were up to 856 ng/g
−1
 (Thomsen et al., 2007), while average compound presence in other 
people was <1 ng/g
−1
 (AMAP, 2009) and accumulation through the environment or products 
is the major risk within this group (Marvin et al., 2011). 
HBCD levels in dietary products are region-dependent (Shi et al., 2009; Roosens et al., 2009). 
The main source of exposure for humans is animal-origin food reach in fat, for instance, fish 
and meat (Shi et al., 2009). The highest concentration of the compound at the present moment 
detected in marine products, especially fish (Knutsen et al., 2008). Besides food, other 
important exposure route is through indoor air, in particular dust (Abdallah et al., 2008). 
HBCD contamination levels are especially high in toddlers as they ingest approximately 200 
mg dust a day and this intake may be 10 times greater than dietary exposure level (Harrad et 
al., 2009). 
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Chart 1.2. Consumption of various BFRs in 2001 and 2005, metric tons. 
 
1.2.3. Toxicity 
In contrast to polybrominated diphenyl ethers there are very few toxicological data available 
on hexabromocyclododecanes. Acute toxic effects of the compound are relatively low 
(Darnerud, 2003). However, there are some data concluding that oral exposure to HBCDs 
induces drug-metabolizing enzymes (for instance, hepatic cytochrome P450) in rats (Germer 
et al., 2006), and that HBCDs may cause genetic recombination leading to cancer (Helleday, 
1999; Ronisz, 2004; Covaci et al., 2006). Moreover it is known that HBCDs affect thyroid 
function, brain development, neuron function, reproduction and development (Marvin et al., 
2011). Furthermore, at the molecular level exposure to HBCD cause oxidative stress, decrease 
in antioxidant defense, disruption of calcium homeostasis, as well as induction of cell death 
(Fonnum & Mariussen, 2009). 
Disruption of thyroid function proved to be a constant response to HBCD. Thyroid 
hyperplasia and lower circulating concentrations of thyroxine (T4) were reported in rats (ACC 
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1, 2001). Later other studies confirmed that HBCD induces thyroid toxicity both in-vivo and 
in-vitro in mammals, fish and birds (Marvin et al., 2011). 
Furthermore, in studies on reproductive system in rats, high concentration of 
hexabromocyclododecanes suppressed oogenesis (Darnerud, 2003). In-vivo studies in rare 
minnow (Gobiocypris rarus) showed that HBCD induced apoptosis, increased formation of 
reactive oxygen species (ROS), causing oxidative damage to lipids, proteins, DNA and 
decline in antioxidant volumes (Zhang et al., 2008). 
 
1.2.3.1.Neurotoxicity 
HBCD influence on the mammalian nervous system is of a particular concern as neuronal 
cells are especially vulnerable to the toxicity. Several in-vivo studies conducted on HBCD 
observed neurotoxic effects of the compound (3–10 mg/kg) in rats. Developmental neurotoxic 
effects after neonatal exposure included aberrations in spontaneous behavior, learning and 
memory function (Eriksson, 2002). Elevation of the normal uptake in neurotransmitters in 
brain was also observed (Fonnum & Mariussen, 2009). 
Very limited information is available regarding in-vitro studies of HBCDs neurotoxicity. 
Recent study showed that HBCD (1-30 µM concentrations) induce dose dependent neuronal 
cell death, ROS formation and increased [Ca
2+
] levels, rapid depolarization of the 
mitochondria and cytochrome c release were also observed (Al-Mousa & Michelangeli, 
2012). 
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1.3.TBBP-A 
Tetrabromobisphenol A is a reactive flame retardant employed primarily in epoxy resins of 
printed circuit boards, but can also be used as an additive in acrylonitrile-butadiene-styrene 
(ABS) resins for electronic enclosures (Birnbaum & Staskal, 2004). Concentrations of TBBP-
A in the environment and biota are quite low, most likely due to its main use as reactive FR 
(approximately 90%). TBBP-A is assumed to be less persistent than HBCD (as it is less 
toxic), and it (according to Covaci et al., 2009; however data not validated) presumably does 
not biomagnify and will unlikely be present at high concentrations in animal-origin food. In 
contrast no information is available for TBBP-A derivatives (Covaci et al., 2009). 
 
1.3.1. Chemical and physical characteristics 
Phenol, 4,4-isopropylidenbis 2,6-dibromo (TBBP-A) is a halogenated aromatic molecule 
(Figure 1.1. b) with a molecular mass of 543.87. TBBP-A, solid at room temperature is 
highly lipophilic and hydrophobic white crystalline powder. Commercial product is usually 
composed of 98% TBBP-A and other 2% made up of several brominated bisphenol A 
compounds (ACC 2, 2001). The industrial manufacturing process implies the bromination of 
bisphenol-A with a solvent addition, for instance, methanol, halocarbon, 50% hydrobromic 
acid or aqueous alkyl monoethers (EHC-172, 1995). 
 
1.3.2. Occurrence and exposure 
At the present moment TBBP-A is the most widespread brominated flame retardant in the 
world with a global consumption of 170,000 tons in 2004 (Birnbaum & Staskal, 2004). 
Tetrabromobisphenol-A is currently manufactured in the USA, Israel and Japan. In the EU it 
can be imported in different forms, e.g. as a primary product or as a complete or unfinished 
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products, for instance, plastics, printed circuit boards and electronic equipment. However, 
limited data are available on quantities imported in EU; overall amount seems to be 
approximately 40,000 tons per year (ERA, 2008). TBBP-A is also employed in derivative 
production, such as TBBP-A dibromopropyl ether, TBBP-A bis(allyl ether), TBBP-A bis(2-
hydroxyethyl ether), TBBP-A brominated epoxy oligomer, and TBBP-A carbonate oligomers 
(EHC-172, 1995). 
High concentrations of tetrabromobisphenol-A were detected in indoor air mostly nearby 
electronics dismantling plants. Furthermore, the compound was discovered in wastewater, 
dust, soil, sewage, sludge and sediment (Covaci et al., 2009). In spite of broad global use of 
TBBP-A, information on its presence in biota is deficient. The compound was found in eggs 
of Norwegian bird species (Herzke et al., 2005), in the blubber of porpoises (Phocoena 
phocoena) (Law et al., 2006) and in several aquatic organisms from the North Sea (Morris et 
al., 2004). 
Generally, data regarding TBBP-A presence in human samples are scarce. Latest human 
studies report that TBBP-A was found mostly in plant workers, since they are occupied in the 
environment where exposure to the compound is much greater. It was also detected in 80% of 
the serum samples from computer technicians, reaching up to 3.4 pmol/g lipid (Jakobsson et 
al., 2002). Major exposure pathway for humans is inhalation of the compound, as its 
concentrations in food are rather low (Sjödin et al., 2003). 
 
1.3.3. Toxicity 
The available information on TBBP-A toxicity is limited. Acute oral toxicity seems to be low. 
However, there are data concluding that compound affects thyroid function, neuron function, 
reproduction and development. Moreover, TBBP-A can produce oxidative stress, decrease 
 18 
J. Sostare, 2013 
antioxidant activity, disrupt calcium homeostasis and induce cell death (Al-Mousa & 
Michelangeli, 2012). 
In contrast to PBDE and HBCD, TBBP-A does not accumulate in fatty tissues, but is bound to 
proteins and retained directly in blood. Due to its similarity to Bisphenol A - environmental 
estrogen – it is possible that TBBP-A may act as endocrine disruptor (Hughes et al., 2000). 
Moreover, 1–12 μM of TBBP-A is able to modify several cell signaling processes (Ogunbayo 
et al., 2007). 
In several studies tetrabromobisphenol-A inhibited thyroid hormone transport function. It 
binds to human transthyretin (TTR) more effectively than thyroxin, showing 10 times higher 
potency over natural ligand (Meerts et al., 2000). TBBP-A also produced anti-thyroidal effect 
in Chinese hamster, as well as inhibited triiodothyronine (T3) binding to thyroid hormone 
receptors in ovary cells (Kitamura et al., 2005). 
In fish, a concentration of 0.5 mg/l decreased survival and growth of young individuals. 
Studies with mice showed that TBBP-A cause decline in body weight, altered spleen weight, 
and decreased concentration of red blood cells, serum proteins, and serum triglycerides (IPCS, 
1995). In a study with zebrafish (Danio rerio) exposed to water-borne TBBP-A, 
disorientation, lethargy, decrease in egg production and low reproductive activity were 
detected (Kuiper et al., 2007). 
Even at low concentrations TBBP-A decreases fluidity of the cell membrane and therefore 
slowing down any biological processes associated with membranes (Lee et al., 1989). As the 
compound appears to be hydrophobic, it is possible that it will bind directly to phospholipid 
bilayers, and as a result it can be concluded that TBBP-A produces cytotoxic effect primarily 
on biological membranes (Pullen et al., 2003; Mariussen & Fonnum, 2002; Reistad et al., 
2002). 
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1.3.3.1.Neurotoxicity 
TBBP-A cause neurotoxic effects in cells, for instance, inhibits neurotransmitter uptake into 
synaptosomes and dopamine uptake into synaptic vesicles in-vitro (Pullen et al., 2003), what 
is followed by free radical formation (Reistad et al., 2002). At relatively low concentrations 
(1-30 µM) it can also raise the level of cytosolic Ca2+ in cerebellar granule cells, which 
triggers cell death mechanism (Reistad et al., 2007). Similarly to HBCD, TBBP-A was able to 
induce cell death, increase ROS formation and elevate [Ca
2+
] levels in neuronal cell line, as 
well as cause depolarization of the mitochondria and cytochrome c release (Al-Mousa & 
Michelangeli, 2012). 
 
1.4. BDE-209 (DBPE or decaBDE) 
Polybrominated diphenyl ethers (PBDEs) – the third most commonly used class of 
brominated flame retardants – include 209 congeners, that are commercially classified as 
three major mixture groups: pentabrominated BDE, octabrominated BDE, and 
decabrominated BDE (Alaee et al., 2003). Decabrominated BDE or BDE-209 is employed in 
electronic equipment (Hardy, 2000) and represents more than 90% of all PBDE worldwide 
production (Fonnum & Mariussen, 2009). As all PBDEs BDE-209 is persistent organic 
pollutant, bioaccumulative in the environment and biomagnified by humans (Darnerud et al., 
2003; Birnbaum & Staskal, 2004; Law et al., 2006). 
 
1.4.1. Chemical and physical characteristics 
BDE-209 (3,30,4,40,5,50,6,60-decabromodiphenyl ether) is a large, bulky molecule (Figure 
1.1. c), with high molecular weight  (959). DecaBDE mixture is made of >97% BDE-209, 
minor amounts of nonaBDEs (BDE-206, BDE-207, BDE-208), and octaBDEs (Goodman, 
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2009). This additive, fully brominated PBDE is almost insoluble in water and partially soluble 
in organic solvents (Costa & Giordano, 2011). DBPE is lipophilic, but due to its size the 
absorption through intestinal tract by passive diffusion is most likely impossible (Morck et al., 
2003). However, recent studies showed that absorption may be solvent-dependent and 
increase from just 10 to 26% (Sandholm et al. 2003). From available data it is assumed that 
BDE-209 has a short half-life and is rapidly excreted, following little accumulation in tissues 
(Costa & Giordano, 2011). 
 
1.4.2. Occurrence and exposure 
PBDEs are extensively employed in a range of consumer products, for instance, textiles, 
carpets, polyurethane foams, electronic cables, television sets and computers. Despite the fact 
that pentaBDE and octaBDE were banned in the European Union and in the USA, BDE-209 
is still globally used and manufactured in the United States and Europe (Costa & Giordano, 
2007). 
Due to additive nature of PBDEs there is a high probability that they can leach from the 
products into the environment. Following recent studies BDE-209 was detected in dust, air, 
sediments, soil, sludge and in various animal species (deWit, 2002; Hites et al., 2004; Law et 
al., 2006; Chen & Hale, 2010; USEPA, 2010). It was also detected in humans, mainly plant 
workers (Gill et al., 2004; McDonald, 2005) and in consumer products. For example, in Texas 
BDE-209 was found in 31 diverse food types (with a highest level in butter) (Schecter et al., 
2010). 
Exposure to decaBDE mainly occurs through food, domestic dust, and the occupational 
setting or can be a mix of all three pathways and is typically age-dependent (Johnson-
Restrepo & Kannan, 2009). 
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1.4.3. Toxicity 
BDE-209 cannot penetrate the cell wall as easy as HBCD or TBBP-A, due to its bulky 
configuration and low absorption rate. Acute and chronic toxicities of the compound are 
rather low, mainly targeting liver and thyroid gland. Furthermore, in some studies altered 
carcinogenicity (elevated tumor formation) was reported (Costa & Giordano, 2011). It is 
assumed that DecaBDE is not genotoxic (Hardy et al., 2009), and NOEL (No Observable 
Effect Level) values for it are relatively high – from a few hundred to several thousand mg/kg 
a day. However, recent studies reported that BDE-209 affects thyroid function, neuronal 
function and causes developmental effects. Moreover, TBBP-A can produce oxidative stress, 
decrease antioxidant activity, disrupt calcium homeostasis and induce cell death. 
Various effects of BDE-209 were detected in-vivo (subacute/subchronic) studies in rats. At 
the dose of 80 mg/kg body wt. thyroid hyperplasia, liver enlargement and hyalin degeneration 
in kidney were seen (IPCS, 1994). Much less data available on BDE-209 effects in-vitro in 
comparison to lower brominated PBDEs. It is know that compound affects thyroid function 
disrupting thyroid hormone mediated transcription at very low concentration (0.01 nM) and 
inhibits thyroid hormone-induced dendrite arborization (Costa & Giordano, 2011). 
 
1.4.3.1.Neurotoxicity 
Limited information is available on neurotoxic effects of BDE-209. Several animal studies 
showed that the compound induces developmental neurotoxicity resulting long-lasting 
changes in locomotor activity and cognitive behaviour. A couple of studies also indicated that 
decaBDE directly affects neuronal cells (Costa & Giordano, 2011). 
Experiments with rat neuronal cells evidenced that BDE-209 (dissolved in dimethylsulfoxide) 
has an effect on hippocampal neurons. At the concentrations of 10.4, 31.2 and 52 µM 
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(approximately 10, 30 and 50 µg/ml) decaBDE induced concentration-dependent reduction of 
cell viability, increased apoptotic cell death and elevated phosphorylation. It also caused 
oxidative stress, resulting ROS formation, malonyldialdehyde (MDA) and nitric oxide 
increase, as well as disrupted calcium homeostasis and reduced antioxidant (superoxide 
dismutase) capacity (Chen et al., 2010). 
Another study also pointed out that at the same concentrations (10, 30 and 50 µM) of the 
compound declined rat hippocampal neuronal cell viability, increased apoptotic cell death and 
elevated intracellular calcium and ROS levels (Zhang et al., 2010). 
Ultimately, in the most recent study Pellacani et al. (2012) reported that BDE-209 caused 
concentration-dependent DNA damage. In this experiment human neuroblastoma cells were 
treated for 4 and 24 hours with the concentrations of 5, 10, and 20 µM. In 4 hours significant 
DNA damage was observed, whereas after 24 hours it was considerably reduced, suggesting 
that DNA repair mechanism has been activated. However, following the treatment with the 
highest concentration no repair was detected (Pellacani et al., 2012). 
 
1.5.Oxidative stress 
1.5.1. Mechanism and specifics 
Aerobic cells constantly consume oxygen, 90% of which is later utilised in electron transport 
chain as well as in nutrient oxidation, followed by the formation of carbon dioxide, water and 
energy. While about 5% of oxygen (under normal conditions) undergo partial one-electron 
reduction resulting addition of electrons and that leads to reactive oxygen species (ROS) 
formation (Lushchak & Semchyshyn, 2012). 
Normally, ROS are rapidly removed from the cell by antioxidant defense system, for instance, 
superoxide dismutase (SOD) or glutathione (GSH) peroxidase (Tocher et al., 2002). However, 
 23 
J. Sostare, 2013 
in a state where the ROS formation exceeds the antioxidant defense an imbalance between the 
ROS creation and elimination is formed. This condition is defined as oxidative stress (Zhang 
et al., 2008). 
There are 3 main causes of oxidative stress: a) a rise in oxidant generation, b) a decline in 
antioxidant defence, c) a failure to repair oxidative damage. The consequences of oxidative 
stress are damage to proteins, lipids, DNA and a decline in antioxidant protection. 
Furthermore, oxidative stress is also associated with mitochondrial damage, because 
mitochondria are both employed in reactive oxygen species formation and serve as targets for 
ROS (Murphy, 2009). The defects formed in DNA are base modifications, single- and double-
strand breaks and apurinic/apyrimidinic site creation, and all those may cause cancer if not 
repaired (Girard and Boiteux, 1997). 
Oxidative stress may also result in the non-specific post-translational protein transformation 
and can induce aggregation of proteins. Human brain uses about 20% of inhaled oxygen, 90% 
of which is employed in production of energy during oxidative phosphorylation; therefore 
neurons are especially sensitive to oxidative stress. Neuronal cells are susceptible to oxidative 
damage due to increased metabolic activity, reduced antioxidant volumes and non-replicative 
nature (Lee et al., 2012).  
  
1.5.2. Reactive oxygen species 
Reactive oxygen species are extremely reactive due to unpaired valence shell electrons. They 
are created as a natural by-product of an oxygen cycle, but can also be produced by 
exogenous sources, for instance, ionizing radiation (Siddique, 2008). ROS are formed during 
the electron transport of mitochondria in a process called aerobic respiration or by 
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oxidoreductase enzymes and metal catalyzed oxidation. The most common reactive oxygen 
species are superoxide, hydrogen peroxide, hydroxyl radical and nitric oxide (Held, 2010). 
For a long time it was clear that ROS are involved in the immune response to microbial 
invasion, eliminating bacteria in cells. However, only recent studies provided evidence that 
they play a crucial role as a messenger in signal transduction and cell cycle, including 
apoptosis and gene expression (Hancock et al., 2001). Elevated ROS levels can induce either 
survival or apoptotic death of the cell, what depends on exposure time and concentration. 
ROS are in charge of such processes as regulation of the blood pressure and redox signaling-
mediated enzyme regulation (Hou et al., 1999). Nevertheless, high levels of reactive oxygen 
species in response to, for example, UV or heat exposure, are toxic for aerobic organisms and 
lead to oxidative stress (Siddique, 2008). 
 
1.5.3. Antioxidant system. Glutathione. 
Antioxidant system is a range of mechanisms that protects cells from the destructive effects of 
ROS. This system includes a number of enzymes and non-enzymatic molecules such as 
superoxide dismutase, catalase, glutathione peroxidase and vitamin C. Glutathione (GSH) 
plays one of the most important roles in protection of cells against ROS (Held, 2010). 
GSH is an ubiquitous thiolic tripeptide (glutamyl-cysteinyl-glycine) that contains a sulphydryl 
group (Jefferies et al., 2003). This group serves as a target for reactive molecules, and as a 
result glutathione is converted from the reduced (GSH) to oxidized form (Jones, 2000). 
Furthermore, reacting with other reactive glutathione (and forming GSSG) this thiol is rapidly 
converted back to GSH. Various functions of GSH include modulating of cell response to 
redox changes, detoxification of the drug metabolites, gene expression control and apoptosis 
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regulation, as well as involvement in transmembrane transport of organic solutes (Jefferies et 
al., 2003). 
 
1.6.Cell death 
PCD (Programmed cell death) is a type of cell death encoded in genes and is crucial for cell 
development and homeostasis of organisms. In embryonic development 3 main mechanisms 
of programmed cell death can be distinguished: apoptosis (cell shrinkage and chromatin 
condensation), necrosis (not always programmed; damage of plasma membrane and 
intracellular content spillage) and autophagy (autophagic vacuole formation). Which 
mechanism will be triggered strictly depends on the nature of the signal, developmental stage 
and the cell type as all mechanisms are connected and one death program can be inhibited and 
replaced by the other (Clarke, 2002). 
 
1.6.1. Apoptosis 
Apoptotic cell death is a main route employed in elimination of unnecessary, old or damaged 
cells, essential for embryonic development, tissue homeostasis and immune regulation (Ellis 
et al., 1991). It is a carefully controlled process with specific morphological and biochemical 
mechanisms. Apoptosis is induced by physiologic and pathologic stimuli and for the normal 
functioning it requires signaling cascade activation, which is regulated by caspases. During 
the apoptotic death the following chain of processes occurs: margination and fragmentation of 
chromatin, cellular shrinkage and fragmentation, and consumption by surrounding cells (Kerr 
et al., 1972). It is believed that apoptotic mechanism is a consequence of a caspase-controlled 
cascade and any divergence from it will cause the cell death by a necrotic pathway 
(Oppenheim et al., 2001). 
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In the cells that undergo apoptosis decreased levels of adenosine triphosphate (ATP) 
transforming to ADP are detected, what may happen due to reduced synthesis of ATP in the 
mitochondria (Eguchi et al., 1999). Also intensive peroxidation is observed in lipid bilayers, 
what result in modification of cell membrane composition. 
Apoptosis may occur by two different but interconnected routes – the cell surface death 
receptor-induced (extrinsic) and the mitochondria-induced (intrinsic) mechanism. The main 
components of the extrinsic mechanism are the adapter protein FADD (Fas-Associated Death 
Domain protein), the death-regulating protease enzyme caspase-8, and FLIP that controls 
caspase-8 activity. These apoptotic proteins are also employed in embryonic development 
(Zeiss, 2003). 
 
1.6.2. Necrosis 
For a long time the nature of necrosis was regarded as a result of accidental and uncontrolled 
physico-chemical stress. However, recently it was proved that necrotic death like apoptosis is 
highly controlled and is pathologically and physiologically significant death pathway, as it 
can eliminate oncogenic cells, which have an ability to avoid apoptosis (Festjens et al., 2006). 
Necrosis can be defined as a process where unrepairable damage of plasma membrane, 
swelling of cytoplasm and collapse of organelles occurs (Fiers et al., 1999). The degradation 
of DNA in necrotic cells proceeds randomly involving a smear-mechanism (Higuchi, 2003). 
Several studies showed that serine/threonine kinase RIP1, which includes a death domain, 
plays a central role in the initiation of necrosis. Major factors that induce necrotic processes 
are disruption of calcium homeostasis and reactive oxygen species formation. They directly or 
indirectly cause damage to proteins, lipids and DNA resulting failure of organelles and cell 
membrane breakdown. Necrotic cells are then lysed, provoking pro-inflammatory signaling 
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cascades (cytokine release) and forcing the contents to leak into the extracellular space 
(Festjens et al., 2006). 
 
1.6.3. Autophagy 
Autophagic cell death is a process where lysosome-mediated degradation of unwanted or 
damaged cellular elements occurs. On a physiological level it is used to keep the organelle 
biogenesis, protein synthesis and their elimination in balance. It also serves as a significant 
mediator of pathological responses and is along with ROS and RNS (reactive nitrogen 
species) employed in cell signalling processes as well as in damage of the proteins (Lee et al., 
2012). 
There are three classes of autophagy: macroautophagy (classic autophagy), microautophagy 
and chaperone-mediated. Macroautophagic mechanism involves the creation of double-
membrane vesicles called autophagosomes that grow and merge with lysosomes for their 
content degradation using acidic hydrolases (Schneider & Zhang, 2010). In microautophagy, 
on the other side, cytosolic components are directly enclosed in lysosomes and ingested by 
them employing membrane involution (Mijaljica et al., 2011; Sahu et al., 2011). Whereas, 
chaperone-mediated autophagy utilizes chaperones to target proteins similar to the 
pentapeptide KFERQ, transporting them to the lysosomes for the elimination (Bejarano & 
Cuervo, 2010). 
It is crucial for the cells to control autophagic process at all stages, especially clearance of 
damaged proteins generating excessive ROS and removal of whole organelles by mitophagy. 
If the process is disrupted at early stage, that results in accumulation of ubiquitous proteins, 
elevated ROS and failure of mitochondria. Likewise, reduced removal of dysfunctional 
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proteins, organelles and DNA via autophagy cause mutations and leads to tumorigenesis 
(Chen & Karantza-Wadsworth, 2009). 
 
1.7.DNA damage 
Initiation of DNA damage is one of the primary stages of chemically caused oncogenesis. 
There are two main pathways of DNA lesion: direct attack of the chemical or its metabolites 
and indirect mechanism of damage related to oxidative stress (Kong et al., 2011). Brominated 
flame retardants are believed to cause DNA damage through ROS formation, as they do not 
result in gene mutations (Pellacani et al., 2012). The consequences of the oxidative stress-
related mechanism are single or double strand breaks and the formation of oxidation products 
such as abasic sites and oxidized bases. DNA single-strand breaks are the most common 
oxidative damage in cells. Their repair is especially important for neurons, as failure to fix the 
damage can lead to mutagenic processes in brain (Hwang & Kim, 2007; Van Loon et al., 
2010; Kong et al., 2011). 
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1.8.Aim and objectives 
The aim of the study is to investigate molecular mechanisms of neurotoxicity by brominated 
flame retardants in SH-SY5Y human neuroblastoma cells. 
Objectives: 
 To evaluate at which concentrations BFRs influence cell viability and determine non-
toxic concentrations; 
 To measure levels of oxidative stress (ROS assay and GSH assay); 
 To assess levels of DNA damage using Alkaline Comet assay; 
 To obtain data regarding the prevailing mechanism of cell death (Apoptosis assay, 
Autophagy assay). 
  
 30 
J. Sostare, 2013 
2. Materials and Methods 
 
2.1. Chemicals 
All chemicals were purchased from Sigma-Aldrich unless stated otherwise. 
 BDE-209 – (97% pure) 1.4 mM solution dissolved in DMSO 
 DMEM – Dulbecco‘s modified Eagle‘s medium with 4500 mg/L glucose, L-
glutamine and sodium pyruvate, pyridoxine, endotoxin tested, sterile filtered. Contains 
2 mM L-glutamine, 1% penicillin (100 units/ml), streptomycin (100 µg/ml), 10% 
(vol/vol) heat-inactivated foetal bovine serum (FBS) and supplemented with 1% 
(vol/vol) non-essential amino acid solution (MEM). 
 DMSO – Dimhethyl sulfoxide (Fisher scientific), sterile 
 HBCD – (95% pure) 2 mM solution dissolved in DMSO 
 PBS – Phosphate Buffered Saline (Dulbecco A) (Oxoid, Basingstoke), containing 
Sodium Chloride (8.0), Potassium chloride (0.2), Di-sodium hydrogen phosphate 
(1.15), potassium dihydrogen phosphate (0.2).               
 TBBP-A – (97% pure) (Acros Organics, UK) 4 mM solution dissolved in DMSO 
 
2.2. Cell culture 
SH-SY5Y neuroblastoma cells (a gift from Frank Michelangeli) were cultured in sterile 
conditions in a Bio Air Aura B4 Class II hood. The hood was sterilized with 70% ethanol 
spray every time before and after use. The working instruments were also disinfected with 
ethanol before application. 
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2.2.1. Defrosting cells 
Cell vial (with 1 ml solution containing frozen cells) was extracted from liquid nitrogen and 
placed in a 37 ºC water bath. When unfrozen, the vial was immediately transferred to the 
hood and all contents were added into 25cm
2
 cell culture flask (T25) (BD Falcon™), 
containing 5 ml of warm DMEM media. The flask was then placed into a humidified chamber 
(5% CO2, 95% air; MCO-15AC, Sanyo, Japan) and incubated at 37 °C. 
 
2.2.2. Cell sub-culture 
When the cells were confluent enough (occupying about 80% of the flask), they were sub-
cultured into 75cm
2
 cell culture flask (T75) (BD Falcon™). Firstly, DMEM was removed 
from T25 and the cells were washed with sterile PBS. After removing PBS trypsin-EDTA (2 
ml) was added to break the attachments between cells, and the flask was incubated in 
humidified chamber at 37 °C for approximately 2 minutes. DMEM media (8 ml) was added to 
the flask and the solution was transferred into 15 ml Falcon tube (BD Falcon™) and 
centrifuged at 1500 rpm for 5 minutes (MSE Falcon 6/300, Sanyo, Japan). Supernatant was 
then removed and cell pellet was resuspended in 1 ml of media, and added to T75 flask with 
15 ml of fresh DMEM. During the study cells were sub-cultured and maintained in T75 
flasks. 
 
2.2.3. Cryopreservation 
Cells were trypsinised and pelleted in a centrifuge (Falcon 6/300) as described above. After 
supernatant removal cell pellet was resuspended in 2 ml of freezing media (1:9 mixture of 
sterile DMSO (10% v/v) and Feotal Bovine Serum) and this solution was transferred to 2 
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cryovials (1 ml each). Cryovials stayed in -80 °C freezer overnight and then were transferred 
into liquid nitrogen. 
 
2.3. Compound dilution 
The right concentrations of compounds were reached using serial dilution. All concentrations 
used for HBCD, TBBP-A and BDE-209 are summarized in Chart 2.1. Firstly, media for 
dilution was prepared (DMEM + 1% DMSO) to obtain same concentration of DMSO in all 
samples. Then the highest compound concentration was reached adding the required 
compound‘s stock solution (stored in a fridge) and DMEM (1:10 in case of BDE-209 or 1:100 
with HBCD, TBBP-A) into 15 ml Falcon tube. The next concentration was reached taking the 
solution from the first tube and adding the same amount of media with DMSO (1:1). This 
dilution was continued till the last tube (except TBBP-A concentration of 15 µM, where 
dilution coefficient was 1:1.67) and finished reaching the lowest concentration. 
Compound Concentration, µM 
HBCD 20 10 5 2.5 1.25 0.625 0.313 0.156 
TBBP-A 40 20 15 10 5 2.5 1.25 0.625 
BDE-209 240 120 60 30 15 7.5 3.75 1.875 
Chart 2.1. BFR concentration spectra (µM) used for MTT assay. 
 
2.4. Viability (MTT) assay 
Cell viability assay was performed (according to Mosmann, 1983) to estimate levels of BFR 
cytotoxity. Cells were cultured in 96-well plates (Corning). The media (100µl) was removed 
and fresh media containing all range of compound concentrations (diluted as above, including 
0 concentration – control) was added. Cells then were incubated for 24 hours at 37 ºC. 
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MTT (3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) stock solution in PBS 
(5mg/ml) was prepared. Compound containing media was subsequently replaced with MTT 
stock solution in DMEM (final concentration 0.5 mg/ml) and stored in humidified chamber 
(37 ºC) for 2 hours. After MTT media was removed and DMSO was added to each well (and 
to 3 spare wells as blank). The absorbance was read employing Bio-Tek FL600 microplate 
reader (Bio-Tek Instruments Inc. USA) at 590 nm. 
 
2.5. Fluorescence spectroscopy 
Levels of oxidative stress (Reactive Oxygen Species formation and glutathione) were 
measured using Fluorescein ROS assay and GSH assay. 
 
2.5.1. Fluorescein ROS assay 
Firstly, cells were cultured in 6-well plates (Corning) and incubated overnight at 37 ºC. Then 
non-toxic compound concentrations (below LC50 – lethal concentration 50%) were added and 
plates were incubated in humidified chamber at 37 ºC for 24 hours. The concentrations used 
for ROS assay are displayed in Chart 2.2. After 23 hours 25 mM H2O2 (hydrogen peroxide) 
was added to one well (for positive control) for 1 hour. Then compound-containing media was 
replaced by DCFDA (2‘,7‘ –dichlorofluorescein diacetate, Cellular Reactive Oxygen Species 
Detection Assay Kit) mixture with DMEM (100 µM final concentration) and plates were 
incubated for 60 minutes at 37 ºC. Again media was removed and cells were washed with 
PBS. Sodium hydroxide (10 mM) was subsequently added, cells were scraped using the cell 
scraper and incubated at room temperature for 15 minutes. After cells were transferred to 
eppendorfs, centrifuged at 13 000 rpm for 5 minutes using a bench-top centrifuge (MSE 
Micro Centaur, Sanyo) and supernatant was then transferred to 3 ml cuvettes. The 
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fluorescence was read using Luminescence spectrometer (Perkin Elmer LS50B, UK; 
excitation wavelength 490 nm and emission wavelength 520 nm). 
Compound Concentration, µM 
HBCD 5 2.5 1.25 0.625 
TBBP-A 20 10 5 2.5 
BDE-209 15 7.5 3.75 1.875 
Chart 2.2. BFR concentrations (µM) used for Fluorescence spectroscopy and Comet assay. 
 
2.5.2. GSH assay 
Buffers: 
 Cell lysis buffer: 0.1% Triton X-100 in PO4-EDTA assay buffer 
 Protein precipitation buffer (TCA 50%): TCA (Trichloroacetic Acid) diluted in 
dH2O (0,5 g/ml) 
 PO4-EDTA assay buffer: 100 mM NaH2PO4, 5 mM Na2EDTA in dH2O; pH – 8.0. 
 O-Phthalaldehyde (OPT): OPT powder in 100% Methanol (1 mg/ml) 
Cells were cultured in 6-well plates and treated with compounds as in ROS assay. After 24 
hours media was removed and cells were washed in PBS. Then ice-cold cell lysis buffer was 
added, cells were scraped into eppendorfs and placed on ice. TCA 50% (vol/vol) was 
subsequently added to lysate, which was centrifuged using a benchtop microfuge at 13 000 
rpm for 5 minutes. After that GSH containing supernatant was transferred to a fresh 
eppendorf. At this stage supernatant was either placed in -80 °C freezer or the assay was 
immediately continued. 
GSH stock was prepared: warmed GSH was mixed with PO4-EDTA assay buffer (0.1 mg/ml). 
Fluorescence cuvettes (3 ml) were used for the assay. PO4-EDTA was added to all cuvettes 
and GSH was transferred to GSH-cuvettes for a standard curve of 0, 1, 2, 4, 6, 8, 10, 12, 14, 
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16, 18 and 20 µg. All GSH containing cuvettes were then supplemented with TCA 5% 
(diluted in water 1:10). After supernatant from each sample was added to the sample-cuvettes. 
Finally, OPT was added to every cuvette, the cuvette-box was shacked, covered and left at 
room temperature for 15 minutes. The fluorescence was read at excitation wavelength of 350 
nm and emission wavelength of 420 nm. 
 
2.5.3. Bradford assay 
After GSH and ROS assays protein concentrations in all samples were determined using 
Bradford assay (Bradford, 1976). First, Bio-Rad protein assay solution was diluted in destiled 
water (1:5), filtered and added to all 1 ml cuvettes. Then BSA (protein) was mixed with PBS 
in eppendorf and added to cuvettes for a standard curve of 0, 2, 4, 6, 8 and 10 µg. Cell 
samples were added into the sample cuvettes and mixed. The absorbance was read at 595 nm. 
 
2.6. Alkaline comet assay 
Buffers: 
 Lysis Buffer: 2.5 M NaCl, 0.1 M Na2EDTA, 10 mM Tris Base dissolved in H2O, pH 
adjusted to 10.0 and supplemented with sodium lauryl sarcosinate (stored at 4°C). 
Before use an aliquot of the buffer was mixed with Triton X-100 (1% final 
concentration) and DMSO (10% final concentration) 
 Electrophoresis Buffer: 9 M NaOH, 20 mM Na2EDTA in dH2O (stored at 4 °C) 
 Neutralization Buffer: 0.4 M Tris Base dissolved in H2O, pH 7.5 (stored at 4°C) 
Slides for the comet assay (Singh et al., 1988) were prepared at least 2 days before: each slide 
was covered with NMPA (Normal melting point agarose 0.5% w/v in PBS) from 1 side. Cells 
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were cultured and treated (same concentrations as for ROS assay) in 6-well plates. After 23 
hours 50, 25 or 12.5 mM H2O2 was added to 1 well (for a positive control) for 1 hour. Media 
was removed and cells were washed in PBS. Then cells were either scraped in PBS or 
trypsinised (modified protocol), added into eppendorfs and pelleted down in the benchtop 
centrifuge at 8 000 rpm for 5 minutes. The pellet was resuspended in PBS. LMPA (Low 
melting point agarose 0.5% w/v in PBS) was then warmed up, placed into eppendorf and 
mixed with sample. The mixture was used to coat a slide and a coverslip was added on top. 
Slides were left on ice for approximately 20 minutes to solidify. When solid, the coverslip 
was removed and slides were transferred to a Coplin jar containing lysis buffer. The jar was 
wrapped in foil and stored in the cold room for 1 hour. After slides were removed from the 
Coplin jar and placed into a large electrophoresis tank, containing electrophoresis buffer, for 
20 minutes. A power pack was turned on at 32 V (300 mA) and electrophoresis was carried 
out for 20 minutes. Then slides were removed and washed with neutralisation buffer 3 times 
for 5 minutes. SYBR gold solution was subsequently prepared (SYBR gold in neutralisation 
buffer, 1:1000), added to each slide and the coverslip was placed on top. Finally, slides were 
transferred to moist box, covered with foil and stored in the cold room overnight. DNA 
damage was evaluated in each slide (100 cells counted) under Axiovert 10 Microscope (Zeiss, 
West Germany) using AVT Smartview camera and Comet 4 Software. 
 
2.7. Vybrant apoptosis assay 
Buffers: 
 1x Annexin-Binding Buffer: 50 mM HEPES, 700 mM NaCl, 12.5mM CaCl2, pH 7.4. 
5x Annexin-Binding Buffer dissolved in H2O (1:4) 
 FITC annexin V: 25 mM HEPES, 140 mM NaCl, 1 mM EDTA, pH 7.4, with 0.1% 
bovine serum albumin (BSA) 
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 Propidium iodide (100 μg/ml): PI solution in 1x Annexin-Binding Buffer 
Cells were cultured and treated (HBCD – 5 µM, TBBP-A – 10 µM and BDE-209 - 15µM in 
supplemented or clear unsupplemented DMEM) in 6-well plates. Then media was removed 
and cells were washed in PBS. Trypsin was added, and cells were incubated for 10 minutes at 
37 °C. Again PBS was added, cells were transferred to eppendorfs and centrifuged at 8 000 
rpm for 5 minutes. Supernatant was removed, pellet was resuspended in PBS and re-
centrifuged. After cells were resuspended in 1x Annexin-Binding Buffer. Propidium iodide 
and FITC annexin V were added to the suspension, and cells were incubated for 15 minutes at 
room temperature. After the incubation period, 1x Annexin-Binding Buffer was added, 
samples were mixed and transferred to the Round-bottom tubes (Falcon®, 352053, Becton 
Dickinson, USA). Stained cells were analyzed using flow cytometer (BD FACS Calibur), 
measuring the fluorescence emission at 470 nm (FITC) and 530 nm (PI). 
 
2.8. Transformation 
First, LB broth (10 g/l Bacto-tryptone, 5 g/l Bacto-yeast extract, and 5 g/l NaCl, pH 7.5 in 
dH2O) and LB/Agar (LB broth, technical agar in dH2O) bacterial growth medium were 
prepared and sterilized by autoclaving. Then kanamycin antibiotic (30 µg/ml) was added to 
the LB/Agar medium and mixture was transferred to Petri plate (Falcon® 353003, Becton 
Dickinson, USA) and left to solidify. 
E. coli Super Competent cells (JM109, Promega) were transformed using pEGFP-C1-LC3 
vector (BD Biosciences). Cells were removed from -70 °C freezer, thawed and transferred to 
15 ml tubes. Then pEGFP-C1-LC3 (50 ng) was added and tubes were placed on ice for 10 
minutes. Cells were heat-shocked in water bath for 45-50 seconds (42 °C) and returned on ice 
for 2 minutes. LB broth (with added kanamycin, 30 µg/ml) was mixed with cells and tubes 
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were incubated for 1 hour at 37 °C (225 rpm) in rotator (Aerotron INFORS AG). After cells 
were transferred to Petri plates and incubated at 37 °C for 12 hours. Grown E.coli colonies 
were used for DNA plasmid isolation experiments. 
 
2.9. Plasmid DNA isolation 
DNA was isolated using ISOLATE Plasmid DNA Mini Kit (Bioline). First, selected colony 
was cultured (in 50 ml tubes, containing LB with kanamycin, 30 µg/ml) in rotator overnight. 
Then the tubes were centrifuged at 6000 rpm for 10 minutes (Mistral 2000, Meadowrose 
Scientific LTD) and supernatant was resuspended in Resuspension buffer. Lysis buffer was 
added and suspension was mixed by inverting. Next, Neutralization buffer was added to the 
mixture and it was centrifuged for 15 minutes at 13 000 rpm to pellet cell debris. After the 
sample was transferred to Spin Column P, inserted in Collection tube and centrifuged for 1 
minute at 10 000 rpm. Filtrate was removed, Wash buffer AP was added and tubes were 
spinned as above. Then Wash buffer BP was added and samples were centrifuged again, 
following the filtrate removal and re-centrifugation at 13 000 rpm for 2 minutes. Spin Column 
P was placed into Elution tube and Elution buffer was added. Samples were incubated at room 
temperature for 1 minute and centrifuged at 10 000 rpm. 
 
2.10. Transfection 
Cells were cultured and transfected in 6-well plates employing Thermo Scientific TurboFect 
Transfection reagent. Serum-free media (unsupplemented DMEM) was mixed with isolated 
plasmid DNA (4 µg) and TurboFect reagent (6 µl). Mixture was incubated at room 
temperature for 15 minutes and then added to each well. For the efficient transfection cells 
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were incubated at 37 °C for 48 hours. GFP (green fluorescence protein) expression was 
monitored using Axiovert 10 Microscope. 
 
2.11. Cell fixing and Autophagy assay 
After transfection cells were treated with compounds (HBCD – 5 µM, TBBP-A – 10 µM and 
BDE-209 - 15µM) and fixed after 0, 4 and 24 hours. Media was removed and cells were 
washed in PBS. Paraformaldehyde solution, 4% (paraformaldehyde powder, PBS, pH 7.4) 
was added to the cells, following the incubation for 15 minutes at room temperature. Then 
cells were washed in PBS (3 times) and left in a fridge (wrapped in foil) until required. 
Autophagic puncta was monitored employing fluorescent Nikon microscope (Japan). 
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3. Results 
 
To investigate neurotoxic effects of brominated flame retardants in human neuroblastoma 
cells, they were treated with diverse concentrations of HBCD, TBBP-A and BDE-209. Cell 
viability levels and non-toxic concentrations (lower than LC50 – lethal concentration 50%) of 
the compounds were determined using MTT assay. These concentrations were further tested 
to evaluate levels of ROS and GSH – main oxidative stress indicators employing 
Fluorescence spectroscopy and DNA damage using Comet assay. All assays were repeated at 
least 3 times. In addition, the preliminary results on the mechanism of cell death were 
analyzed by apoptosis and autophagy assays. 
 
3.1. MTT assay 
An impact of brominated flame retardants on cell viability was measured to estimate the 
levels of their cytotoxicity. Wide range of concentrations (Chart 2.1) was used to evaluate the 
survival of cells after BFR exposure. Colorimetric MTT assay, where MTT agent is reduced 
to a violet formazan product (in metabolically active cells), was used to determine the number 
of viable cells. 
All compounds showed concentration-dependent decrease in cell viability (Chart 3.1-3.3), 
but HBCD proved to be the most toxic for the cells. There was a slight shift in number of 
viable cells at very low concentrations with HBCD (from 0.156 – 1.25 µM) and TBBP-A 
(from 1.25 – 5 µM), which was followed by a sharp drop in viability at the concentrations 2.5 
and 10 µM respectively. In contrast the third compound – BDE-209 constantly followed the 
trend of gradual reduction in cell viability. 
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LC50s were calculated to estimate at which concentration cell viability was 50% and LC50 
values (or lower) were used for further experiments. The lethal concentrations, 50% were 
between 2.5 and 5 µM, 15 and 20 µM, 30 and 60 µM for HBCD, TBBP-A and BDE-209 
respectively. 
 
Chart 3.1. Influence of HBCD on SH-SY5Y cell viability. Cells were incubated with HBCD for 24 
hours at different concentrations (0-20 µM). Cell viability (abs. 590 nm) was measured using MTT 
assay. Final absorbance calculated against DMSO blank, data points are mean values of 9 
measurements ±Standard error (3 independent experiments). *Asterisks indicate significant values 
(p<0.05) calculated by Student‘s T-test. 
 
 
Chart 3.2. Influence of TBBP-A on cell viability. Cells were incubated with TBBP-A for 24 hours at 
different concentrations (0-40 µM). Cell viability (abs. 590 nm) was measured using MTT assay. Final 
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absorbance calculated against DMSO blank, data points are mean values of 9 measurements ±Standard 
error (3 independent experiments). *Asterisks indicate significant values (p<0.05) calculated by 
Student‘s T-test. 
 
 
Chart 3.3. Influence of  BDE-209 on cell viability. Cells were incubated with BDE-209 for 24 hours 
at different concentrations (0-240 µM). Cell viability (abs. 590 nm) was measured using MTT assay. 
Final absorbance calculated against DMSO blank, data points are mean values of 9 measurements 
±Standard error (3 independent experiments). *Asterisks indicate significant values (p<0.05) 
calculated by Student‘s T-test. 
 
3.2. Fluorescence spectroscopy 
3.2.1. Fluorescein ROS assay 
ROS formation was measured to determine the oxidative stress in cells. Four concentrations 
(Chart 2.2) for each compound were selected for the assay. Reactive oxygen species were 
detected using fluorescein ROS assay, where DCFDA reagent is oxidized by ROS into 
fluorescent DCF (2‘, 7‘ –dichlorofluorescin). The efficiency of the assay was verified by a 
positive control (50 µM H2O2), which cause elevated ROS formation. The fluorescence was 
measured between 490 and 520 nm and converted to ―fluorescence per µg of protein‖, 
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to be toxic as was killing the cells in 24 hours (before the assay) and therefore was excluded 
from the analysis. One of three compounds – HBCD (Chart 3.4) showed no concentration-
dependent response in the assay. ROS formation with BDE-209 (Chart 3.6) slightly 
increased, but no in statistically significant manner. In contrast considerable concentration-
dependent increase in ROS was detected with TBBP-A (increasing more than two times at the 
highest concentration – 10 µM in comparison to the control, Chart 3.5). 
 
Chart 3.4. ROS production in HBCD treated SH-SY5Y cells. Fluorescein oxidation was detected 
using DCFDA after 24 hours treatment at different HBCD concentrations (0-5 µM) and compared to 
positive control (H2O2). Final values were calculated proportionally to the amount of protein (µg) 
obtained in Bradford assay. Data points represent mean values of 3 measurements ±Standard error (3 
independent experiments). 
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Chart 3.5. ROS production in TBBP-A treated cells. Fluorescein oxidation was detected using 
DCFDA after 24 hours treatment at different TBBP-A concentrations (0-10 µM) and compared to 
positive control (H2O2). Final values were calculated proportionally to the amount of protein (µg) 
obtained in Bradford assay. Data points represent mean values of 3 measurements ±Standard error (3 
independent experiments). 
 
 
Chart 3.6. ROS production in BDE-209 treated cells. Fluorescein oxidation was detected using 
DCFDA after 24 hours treatment at different BDE-209 concentrations (0-15 µM) and compared to 
positive control (H2O2). Final values were calculated proportionally to the amount of protein (µg) 
obtained in Bradford assay. Data points represent mean values of 3 measurements ±Standard error (3 
independent experiments). 
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3.2.2. GSH assay 
In conjunction with the ROS assay the levels of glutathione were measured to indicate 
oxidative stress in cells. The concentrations of the compounds were selected as in ROS assay 
(also excluding 20 µM concentration). GSH assay was used to detect levels of glutathione in 
cells, involving transformation of luciferin derivative into fluorescent luciferin in the presence 
of GSH. The fluorescence was measured between 350 and 420 nm and was converted into µg 
of GSH per µg of protein (involving Bradford assay). 
Two compounds – TBBP-A and BDE-209 (Chart 3.8., 3.9) showed only random 
insignificant changes in GSH levels, therefore no response was detected. On contrary, HBCD 
(Chart 3.7) considerably decreased levels of GSH. The results indicated more than 3 fold 
depletion of GSH at the highest concentration of 5 µM compared to the control. 
 
Chart 3.7. GSH quantities in SH-SY5Y cells treated with HBCD. GSH fluorescence was measured 
after 24 hours (0-5 µM concentration range) treatment with HBCD using GSH assay. Fluorescence 
was converted into µg of GSH present in 1 µg of protein (Bradford assay). Data points are mean 
values of 3 measurements ±Standard error (3 independent experiments). *Asterisks indicate significant 
values (p<0.05) calculated by Student‘s T-test. 
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Chart 3.8. GSH quantities in cells treated with TBBP-A. GSH fluorescence was measured after 24 
hours (0-10 µM concentration range) treatment with TBBP-A using GSH assay. Fluorescence was 
converted into µg of GSH present in 1 µg of protein (Bradford assay). Data points are mean values of 
3 measurements ±Standard error (3 independent experiments). 
 
 
Chart 3.9. GSH quantities in cells treated with BDE-209. GSH fluorescence was measured after 24 
hours (0-15 µM concentration range) treatment with BDE-209 using GSH assay. Fluorescence was 
converted into µg of GSH present in 1 µg of protein (Bradford assay). Data points are mean values of 
3 measurements ±Standard error (3 independent experiments). 
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3.3. Comet assay optimization 
Alkaline comet assay is a very sensitive, relatively simple and cheap method for DNA single-
strand break detection. The principle of the comet assay involves negatively charged DNA 
nucleoids that migrate from cathode to anode. Comet slides are then stained with SYBR gold 
fluorescent dye and viewed under the fluorescent microscope, where represent bright orange 
spheres (Figure 3.1. a, b) if not damaged and tailed comets (Figure 3.1. c, d) if strand breaks 
occurred. 
 
Figure 3.1. Undamaged cells a), b) and cells with DNA damage c), d) under fluorescent microscope 
after Comet assay. During electrophoresis DNA migrates from anode to cathode, creating comet-like 
structures, if DNA strand breaks occurred (pictures made using AVT Smartview software). 
 
3.3.1. Stage 1. Preliminary data. 
First comet assay stage was performed according to the general protocol. For the positive 
control 50 µM H2O2 (1:2000 in DMEM) was used to verify that the assay is working and 
DNA damage occurs. After the treatment cells were scraped in PBS and then the rest of assay 
steps were carried out through all study without modifications. 
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Chart 3.10. BFR caused DNA damage in SH-SY5Y cells. Preliminary data. Comet tail intensity 
(%), which indicates the percentage of DNA single-strand breaks was measured following 24 hours 
treatment with HBCD (0-2.5 µM) and TBBP-A (0-10 µM) employing Comet assay. Each data point is 
a mean value of 100 measurements (cells recorded). 
 
The results of the first comet assay stage (Chart 3.10) indicated damaged negative control 
(tail intensity – 23.2%, while normally is only 2-4%) and very high overall damage in all 
samples. Moreover, in the positive control as well as in 2 tested concentrations (5 µM for 
HBCD and 20 µM for TBBP-A, later excluded as in previous assays) DNA damage was 
undetectable – during the analysis only random DNA fragments were identified and no 
comets were observed. However, at this stage a concentration-dependent increase was already 
evident for 2 compounds – HBCD and TBBP-A. 
 
3.3.2. Stage 2. Optimization. 
Optimization step was carried out to reduce the high damage in samples detected at the first 
stage. For better performance the protocol was modified for SH-SY5Y cell type. The results 
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trypsin instead of scraping. Two dilutions were carried out to reduce the damage in positive 
control – 25 mM of H2O2 (1:4000 in DMEM) and 12.5 mM of H2O2 (1:8000 in DMEM). 
Still, the cells were too damaged after an hour treatment – comets were too fragmented, and 
as a result excluded from the analysis. 
 
3.4. Alkaline Comet assay 
Optimization step noticeably improved comet assay performance. The negative control value 
significantly declined (being within norm – 2.5%) and DNA damage within samples 
decreased as well.  
Results of the comet assay indicated same trend with all compounds – DNA damage 
considerably increased in a concentration-dependent manner (Chart 3.11-3.13). Even at 
lowest concentration the percentage of single-strand breaks doubled with all three 
compounds. HBCD was the most potent chemical in the assay, increasing almost 6 fold at the 
highest concentration used (5 µM) in comparison to the control and causing considerable 
DNA damage in cells. 
 
Chart 3.11. DNA damage in HBCD treated SH-SY5Y cells. Comet tail intensity (%) was measured 
following 24 hours treatment with HBCD (0-5 µM) using comet assay. Each data point represents a 
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mean value of 300 measurements ±Standard error (3 independent experiments). *Asterisks indicate 
significantly different values (p<0.05) calculated by Student‘s T-test. 
 
 
Chart 3.12. DNA damage in TBBP-A treated cells. Comet tail intensity (%) was measured 
following 24 hours treatment with TBBP-A (0-10 µM) using comet assay. Each data point represents a 
mean value of 300 measurements ±Standard error (3 independent experiments). *Asterisks indicate 
significantly different values (p<0.05) calculated by Student‘s T-test. 
 
 
Chart 3.13. DNA damage in BDE-209 treated cells. Comet tail intensity (%) was measured 
following 24 hours treatment with BDE-209 (0-15 µM) using comet assay. Each data point represents 
a mean value of 300 measurements ±Standard error (3 independent experiments). 
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3.5. Apoptosis assay. Preliminary results 
Apoptotic or necrotic cell death pathway was determined using vybrant apoptosis assay. The 
type of the cell death was identified employing FITC annexin V and Propidium iodide 
labeling. Annexin V is an anticoagulant that binds to phosphatidylserine, which in apoptotic 
cells is transferred to the outer membrane layer (in live cells it is found on cytoplasmic 
surface). Annexin contains fluorophore or biotin that labels apoptotic cells. PI dye in contrast 
labels necrotic cells, as passing through the damaged membrane binds directly to the nucleic 
acids. Cells stained with the reagents express green fluorescence, if they are apoptotic, red and 
green fluorescence being necrotic and show almost no fluorescence, if they are alive. 
To evaluate the efficiency of the assay in different environment compounds were diluted in 2 
medias – serum free and serum present DMEM. Three parameters of the assay were defined 
and analyzed (Figure 3.2-3.4) – percentage of cellular debris (fluorescent objects smaller in 
size than the cell), PI and FITC staining. The percentage of cellular debris (Chart 3.14) 
increased in cells treated in serum present media with HBCD and TBBP-A compared to the 
serum free cells, but decreased with BDE-209. The highest percentage of debris was observed 
in cells exposed to HBCD. 
 
Chart 3.14. Percentage of cell debris in BFR treated SH-SY5Y cells. Following 24 hours treatment 
with HBCD (5 µM), TBBP-A (10 µM) and BDE-209 (15 µM) in presence and absence of serum 
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percentage of fragments smaller than cell size was measured by flow cytometry. Necrotic cell 
fragments and apoptotic bodies due to their size are not present in FITC and PI analysis as are not 
whole cells, therefore are often quantified as cell debris. 
 
The percentage of necrotic cells was determined using PI labeling (Chart 3.15). The highest 
amount of cells stained with PI was observed with HBCD. The percentage of PI labeled cells 
was greater with serum in HBCD and TBBP-A samples and smaller in BDE-209. In contrast, 
the amount FITC stained cells (Chart 3.16) considerably increased in serum free media, with 
TBBP-A (almost twice) and especially with HBCD (rising almost 6 times). BDE-209 again 
showed the different trend decreasing in serum free media.  
Overall, all compounds showed increased FITC annexin V staining in comparison to the 
control. HBCD proved to be the most potent also demonstrating increased Propidium iodide 
labelling. 
 
 
Chart 3.15. Percentage of necrotic cells after BFR treatment. Following 24 hours treatment with 
HBCD (5 µM), TBBP-A (10 µM) and BDE-209 (15 µM) in presence and absence of serum percentage 
of PI stained cells was measured by flow cytometry. 
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Chart 3.16. Percentage of apoptotic cells after BFR treatment. Following 24 hours treatment with 
HBCD (5 µM), TBBP-A (10 µM) and BDE-209 (15 µM) in presence and absence of serum percentage 
of FITC annexin V fluorescent cells was measured by flow cytometry. 
 
 
Figure 3.2. FITC fluorescence in SH-SY5Y (serum-free) cells. Lines represent negative control cells 
(white), cells treated with HBCD (orange), TBBP-A (red) and BDE-209 (green).
0
5
10
15
20
25
30
35
Control BDE 15 BDE 15
(serum)
TBBP-A
10
TBBP-A
10
(serum)
HBCD 5 HBCD 5
(serum)
FI
TC
 f
lu
o
re
sc
e
n
t 
ce
lls
, %
 
Concentration, µM 
 54 
J. Sostare, 2013 
    
 
   
Figure 3.3. Cellular debris in SH-SY5Y cells. Green color represent viable cells, red – cellular debris in negative control cells, cells treated with HBCD, TBBP-A 
and BDE-209 in serum-free (top) and serum-present (bottom) medias. 
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Figure 3.4. Propidium iodide staining in SH-SY5Y cells. Green color represent viable cells, red –PI labelled (necrotic) in negative control, cells treated with HBCD, 
TBBP-A and BDE-209 in serum-free (top) and serum-present (bottom) medias. 
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3.1. Autophagy. Preliminary results 
Recombinant DNA technology using the transformation process involves the formation of 
selected DNA fragment clones. The fragment required is bonded to E.coli plasmid vector, 
replicative inside a host cell. This recombinant DNA molecule, containing drug-resistance 
gene, Enhanced Green Fluorescent Protein (EGFP) gene and LC3 protein (rat microtubule-
associated protein 1 light chain 3) inserted into the cell produces millions of copies of the 
required fragment (Lodish et al., 2000). Following general protocol, E. coli Super Competent 
cells were successfully transformed using pEGFP-C1-LC3 vector. Plasmid DNA was then 
isolated from three E. coli transformed colonies and isolation efficiency was then monitored 
measuring DNA absorbance (260 nm) for all clones obtained (being 0.217, 0.368 and 0.337 
µg/µl for Clone 1, 2 and 3 respectively). 
After SH-SY5Y cells were transfected (Figure 3.5. a, b) with plasmid DNA, employing 
TurboFect reagent – cationic polymer, that creates stable and positively charged structures 
with DNA. Transfection efficiency was examined under fluorescent microscope. Around 60-
70% of cells expressed green fluorescent protein (no fluorescence observed in negative 
control), what makes the results of transfection very effective. Transfection reagent however 
was slightly toxic for the cells; nevertheless in general cell viability was not considerably 
affected. 
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Figure 3.5. GFP expression a), b) and cytoplasmic puncta (autophagy) c), d) in transfected 
SH-SY5Y cells. 
 
After 48 hours transfected cells, treated with compounds, were fixed and monitored under the 
fluorescent microscope. Autophagic process was examined in GFP positive, treated cells. The 
principle of autophagy assay involves GFP-LC3 fusion gene expression that permits to 
visualize the development of autophagic vesicles in cells. At the stage of autophagosome 
formation GFP-LC3 binds to the autophagosome membrane and can be observed as a 
cytoplasmic puncta (Figure 3.5. c, d). 
In preliminary experiment (using standard media) after 0 and 4 hours treatment no punctate 
cells were detected in samples. In 24 hours some cells were punctate in samples with HBCD 
and TBBP-A, however generally no significant changes were observed. Nevertheless, in 
another autophagy experiment in cells treated with HBCD (diluted in clear serum-free media) 
only for 2 hours considerable changes were detected. Percentage of cytoplasmic puncta 
increased from 21 to 50% compared to the control. 
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Chart 3.17. Autophagic puncta in SH-SY5Y cells treated with HBCD. Cells were treated with 0 
and 6 µM HBCD for 2 hours. Autophagic puncta was calculated in 19 quadrants (103 cells in total) for 
the control and in 23 (98 cells in total) for HBCD. Data points represent percentage of autophagy in 
cells ± Standard error. 
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4. Discussion 
 
During the last decade growing consumption of BFRs raised the concern of their toxic impact 
on the environment and human health. BFR effects on nervous system and neuronal 
development have been in focus for the past few years as some studies indicated BFR ability 
to cross the blood barrier and accumulate within brain tissue (Szabo et al., 2010). The 
neurotoxic effects observed after the exposure include aberrations in spontaneous behaviour, 
learning and memory function (Eriksson, 2002; Costa & Giordano, 2011).  In-vitro studies 
showed that HBCD, TBBP-A and BDE-209 reduce cell viability, increase ROS formation and 
elevate [Ca
2+
] levels in neuronal cells, as well as cause depolarization of the mitochondria and 
cytochrome c release (Al-Mousa & Michelangeli, 2012). However, the information regarding 
in-vitro neurotoxicity of HBCD, TBBP-A and BDE-209 is still scarce. Therefore, in this 
report the ability of these three compounds to decrease cell viability, cause oxidative stress 
and DNA damage was evaluated. Additionally, cell death mechanisms were also studied. 
 
4.1. BFR cytotoxicity 
In current report MTT assay results indicated that HBCD, TBBP-A and BDE-209 induce 
concentration-dependent decrease in cell viability, with HBCD being the most potent of all 
compounds (LC50 between 2.5 and 5 µM, 15 and 20 µM, 30 and 60 µM for HBCD, TBBP-A 
and BDE-209 respectively). Recent study confirmed depletion in cell viability in SH-SY5Y 
cells with all three chemicals after 24 hours exposure and also proved that HBCD (0-30 µM 
range used) is the most toxic compound. Similar LC50 values were identified being 2.7±0.7 
µM for HBCD, 15±4 µM for TBBP-A and 28±7 µM for BDE-209 (Al-Mousa & 
Michelangeli, 2012). In previous study on TBBP-A (using 0-50 µM range) gradual decrease 
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in cell viability after 18 hours in mouse TM4 Sertoli cells was detected, with LC50 being 18 ± 
6 µM (Ogunbayo et al., 2008). Other reports showed that in 24 hours BDE-209 decreases cell 
viability in rat hippocampal neurons at the concentrations of 10, 30 and 50 µM (Zhang et al., 
2010; Chen et al., 2010). 
 
4.2. Oxidative stress 
Following the exposure to various compounds, for instance BFRs, elevated levels of reactive 
oxygen species are formed, what leads to oxidative stress. Consequently, ROS levels are one 
of the main oxidative stress parameters (Siddique, 2008). The results of this research showed 
that concentration-dependent increase in reactive oxygen species occurs only in cells exposed 
to TBBP-A, what indicates that TBBP-A is able to cause oxidative stress at non cytotoxic 
concentrations. The most recent study, however, demonstrated that in SH-SY5Y cells at 
similar concentrations HBCD (1, 3, 5, and 15 µM) as well as TBBP-A (5 µM) cause gradual 
increase in ROS (after 24 hours). BDE-209 (5 µM) in the same study showed no significant 
changes in ROS in comparison to the control (Al-Mousa & Michelangeli, 2012). Latest in-
vivo research in rare minnow (Gobiocypris rarus) indicated that 28 and 42 day exposure to 
waterborne HBCD induces elevation of ROS (in brain) at 0.001, 0.01, 0.1 and 0.5 µM 
concentrations (Zhang et al., 2008). Studies in rat hippocampal neurons showed that BDE-209 
considerably increases ROS levels at 10, 30 and 50 µM concentrations in 24 hours (Zhang et 
al., 2010; Chen et al., 2010). 
Antioxidants and in particular GSH are the main cell defense system that remove ROS from 
the cell and prevent oxidative stress (Tocher et al., 2002). Therefore, decrease in GSH and 
elevated ROS formation – two main indicators of oxidative stress are closely connected 
(Chuang & Chen, 2004). In current study the reduction of GSH in a concentration-dependent 
manner was observed only with HBCD, but not in cells treated with TBBP-A. That is rather 
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puzzling as makes 2 major parameters of oxidative stress – increase in ROS and depletion of 
GSH unrelated in current experiments. This may occur due to lowered assay sensitivity or 
errors, or the probability that compounds induce toxic reaction through other mechanisms, 
therefore future experiments are required. In-vivo research in rare minnow (Gobiocypris 
rarus) showed that waterborne HBCD (at 0.001, 0.01, 0.1 and 0.5 µM concentrations) after 28 
and 42 day exposure induces significant depletion of glutathione (Zhang et al., 2008).  
 
4.3. Genotoxicity 
DNA damage is a crucial factor in many human disorders including genetic diseases and 
cancer. DNA strand breaks can be induced by several factors such as increase in reactive 
oxygen species, UV radiation or various chemicals (McKenna et al., 2008). Comet assay was 
created as a one of the most sensitive methods for DNA single-strand break detection in 
individual cells (Collins, 2008; McKenna et al., 2008; Tice et al., 2008). It is referred to as a 
rather fast method suitable for all animal cells. However, the assay is not standartized, 
therefore optimization and analysis is time consuming and can involve several modifications 
for a particular cell type, also the process consists of many stages (requires a huge effort and 
preciseness). In addition, the assay is unable to identify small DNA fragments, mitochondrial 
DNA and apoptotic cells as they are washed during the lysis and electrophoresis (Nossoni, 
2008). The problems during the experiment often include too damaged negative control, 
absence of tails or undetectable comets in positive control, or bubbles in agarose. 
Nevertheless, after successful optimization stage the assay is able to generate excellent 
results. 
Modified comet assay showed considerable concentration-dependent increase in DNA single-
strand breaks with all compounds tested, especially with HBCD. The most recent study in 
SK-N-MC human neuroblastoma cells indicated that BDE-209 similarly to its lower 
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brominated congener BDE-47 (tetrabromodiphenyl ether) cause DNA damage at 5, 10, and 20 
µM concentration in 4 and 24 hours (Pellacani et al., 2012), however in current study the 
trend was not strong enough to suggest that, therefore future experiments are essential. 
Another study on BDE-47 confirmed that it induces DNA damage in SH-SY5Y neuronal cells 
at 2 µM concentration, without detectable impact on cell viability (He et al., 2009). An in-vivo 
study in rare minnow showed that waterborne HBCD induces DNA damage (at 0.001, 0.01, 
0.1 and 0.5 µM concentrations) in fish blood cells following 28 and 42 day exposure (Zhang 
et al., 2008). However, no studies investigated the ability of HBCD and TBBP-A to cause 
DNA strand breaks in-vitro, and the results obtained with these two compounds are novel. 
 
4.4. Mechanisms of cell death 
To understand the molecular mechanisms of BFRs it is crucial to know by which mechanism 
they cause cell death. Preliminary results of the current study indicated that cell death induced 
by BFRs occurs mostly via apoptosis with TBBP-A and BDE-209, whereas HBCD is able to 
cause cell death via both mechanisms (apoptosis and necrosis). Latest study indicated that all 
three BFRs (HBCD, TBBP-A, BDE-209) cause caspase-dependent apoptosis in SH-SY5Y 
neuroblastoma cells (Al-Mousa & Michelangeli, 2012). Previous report on TBBP-A in mouse 
TM4 Sertoli cells confirmed that the compound induces cell death via apoptosis, however 
specified the possibility that other cell death mechanisms are employed as well (Ogunbayo et 
al., 2008). Studies in rat hippocampal neurons indicated that BDE-209 cause apoptotic cell 
death (Zhang et al., 2010; Chen et al., 2010). Another report on human hepatoma cells HepG2 
confirmed that BDE-209 induces cell death by apoptotic mechanism (Hu et al., 2007). One 
more in-vivo research in zebrafish embryos also showed that HBCD cause cell death via 
apoptosis (Deng et al., 2009). To confirm the results obtained in the preliminary experiments 
of this report additional research is needed. 
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Autophagy – a complex catabolic process for lysosomal degradation of proteins and other 
subcellular constituents is usually initiated as a response to nutrient deficiency. It is a key 
factor in aging, cancer and neurodegeneration prevention, as well as in elimination of 
intracellular pathogens (Dunn, 1994). Mammalian protein LC3 plays the main role in 
autophagic assays as associates with autophagosome membrane and in complex with GFP is 
detectable as fluorescent puncta (Kabeya et al., 2000). 
For autophagy monitoring 60-70% transfection efficiency was reached, what is similar to 
previous studies in human cervical carcinoma HeLa cells, transfected for 12 hours with 70% 
transfection efficiency obtained (Criollo et al., 2010). So far no studies assessed the ability of 
brominated flame retardants to induce autophagy, however previous report on other flame 
retardant group – polychlorinated biphenyls (PCB) indicated that PCBs cause deregulated 
autophagy in sheep blastocysts (Ptak et al., 2012). The autophagy experiment indicated that 
HBCD can induce autophagy in SH-SY5Y cells, therefore suggesting that all three 
mechanisms are employed in HBCD toxicity-caused cell death. However, further research is 
required to confirm the results obtained with HBCD and to determine if autophagy occurs 
with TBBP-A and BDE-209 as well. 
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5. Conclusions 
 
The molecular mechanisms of neurotoxicity by three brominated flame retardants – HBCD, 
TBBP-A and BDE-209 were explored in this study. The results showed that all three 
compounds and, especially HBCD, are cytotoxic for SH-SY5Y cells as they decreased cell 
viability in µM concentrations. Cell death induced by HBCD, TBBP-A and BDE-209 occurs 
mainly via apoptotic mechanism, whereas HBCD is also able to induce cell death via necrosis 
and autophagy. However, further research on cell death mechanisms is required to confirm 
this preliminary data. Following the results of fluorescence spectroscopy increased ROS 
formations were observed only with TBBP-A and depletion of GSH was detected only with 
HBCD. From this data it can be concluded that either the assay sensitivity is low, 
optimization of the assay is needed or another mechanisms are employed in oxidative stress 
caused by BFRs. Novel comet assay results indicated that all compounds cause DNA damage 
in human neuroblastoma cells as considerably increase the percentage of single-strand breaks 
at non-toxic concentrations. The highest DNA damage is caused by HBCD, whereas BDE-
209 is least potent due to its low solubility. Therefore, it can be concluded that all three BFRs 
are not only neurotoxic, but also genotoxic at very low concentrations in SH-SY5Y cell in-
vitro. 
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Appendix I. Conferences and publication 
This work was presented on British Toxicology Society Annual Congress in Solihull (United 
Kingdom) in April 2013 under the following title: “Induction of oxidative stress and single 
strand DNA breaks by brominated flame retardants in SHSY-5Y neuronal cells‖. 
It was also featured (as a poster) in 46
th
 Congress of the European Societies of Toxicology, 
EUROTOX in September 2013 in Interlaken Switzerland under following title: ―An 
investigation into the toxicity and genotoxicity of brominated flame retardants in SHSY‐5Y 
cells‖.  
Consequently the abstract from EUROTOX congress was also published in Toxicology 
Letters: Volume 221S, S140, P12-11, August 2013; and can be viewed, following the link: 
http://dx.doi.org/10.1016/j.toxlet.2013.05.278  
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Abstract 
Nowadays, multidrug resistant bacteria are one of the greatest human concerns as they 
commonly cause illness and death. A new widely-used technique – high-throughput (HTS) 
whole-genome sequencing, allows rapid genome finishing thus providing all of the resistance 
information (and more), and helps to find the appropriate cure or even prevent bacterial 
outbreaks rapidly and in just one step. Therefore, this study attempted to finish the genome of 
multidrug-resistant Elizabethkingia meningoseptica 501 (induce meningitis in infants) and 
start finishing the genome of a new Pseudomonas aeruginosa ST395 strain (caused an 
outbreak in Birmingham hospital in burn victims), employing whole-genome Nextera XT and 
Mate Pair sequencing (Illumina). Optimization of Nextera XT for organisms with different 
GC content was also carried out in the study using 3 species – Escherichia coli (Medium GC), 
Pseudomonas aeruginosa (high GC) and Elizabethkingia meningoseptica (low GC). Nextera 
XT results indicated a concentration-dependant increase in E. coli samples and allowed to 
obtain contiguous sequences for each genome. Furthermore, Mate Pair sequencing enabled 
joining contigs into scaffolds. PCR reactions and Sanger sequencing allowed closing 
sequencing gaps and start finishing the genome of E. meningoseptica, finally obtaining 4 
gapped fragments of E. meningoseptica genome. Mate Pair sequenced genomes were further 
analysed and annotated, showing different resistance patterns of each bacterium. Relation to 
other bacterial strains were further determined building a phylogenetic tree. Nevertheless, 
technological progress made HTS a powerful scientific tool, which can perform fast and 
efficient genome finishing thereby minimizing the effort and also providing an exceptional 
quality of the data. 
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1. Introduction 
 
For many centuries microorganism-induced infectious diseases remained one of the most 
common causes of human illness and death. After invention and successful development of 
antibiotics it was assumed that all infectious diseases as well as disease experts will soon 
disappear. However, bacterial populations exposed to antibiotic stress demonstrated the 
opposite, starting a new era of infectious diseases during past 30 years. Bacterial organisms 
were able to effectively adapt in their environment and develop a resistance against drugs. 
Many strains became multidrug resistant, which is a rising concern nowadays as this can lead 
to panresistance and complete futility of medications. Currently the most challenging bacterial 
pathogens with developed drug resistance include numerous gram-positive bacteria 
(methicillin-resistant Staphylococcus aureus, multidrug-resistant Streptococcus pneumoniae, 
vancomycin- resistant Enterococcus spp.) as well as various gram-negative bacteria such as 
multidrug-resistant Acinetobacter baumannii, Klebsiella pneumoniae, Escherichia coli, 
Pseudomonas aeruginosa and Elizabethkingia meningoseptica (Lister et al., 2009). 
 
1.1. Elizabethkingia meningoseptica 
1.1.1. Biology and distribution 
The genus of Elizabethkingia includes aerobic, Gram-negative, rod-shaped bacteria, which are 
non-motile and produce yellow coloration during the culture (rarely can be non-pigmented). 
Until 2011 only two species were representing the genus – Elizabethkingia meningoseptica 
and Elizabethkingia miricola (Bernardet et al., 2006), however in 2011 a new species – 
Elizabethkingia anophelis was discovered in the midgut of the mosquito Anopheles gambiae 
(Kämpfer et al., 2011). Both E. meningoseptica and E. miricola are able to cause human 
 12 
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infections, however E. meningoseptica is more potent pathogen and more often is associated 
with severe diseases. E. meningoseptica, earlier known as Flavobacterium meningosepticum 
and Chryseobacterium meningosepticum, is widely spread in the environment, especially in 
soil and water (Steinberg & Burd, 2010). Similar to P. aeruginosa, E. meningoseptica often 
infects immuno-compromised and postoperative patients as well as infants (Jacobs & Chenia, 
2011). 
The biotopes, inhabited by E. meningoseptica vary, but mostly have high humidity level.  
Those are different water bodies such as lakes and other freshwater, soil, nuclear fuel pools or 
even space (Bernardet et al., 2006). Bacterium was also isolated from various eukaryotic 
organisms, for instance, protozoa, fish, amphibians, reptiles, birds and mammals. In medical 
units E. meningoseptica is often isolated from many sources, including freshwater and saline 
solutions, disinfectants, medical equipment and devices, such as feeding tubes, respirators and 
catheters (Ceyhan et al., 2008). 
 
1.1.2. Clinical picture 
E. meningoseptica can be a part of normal microflora in different organisms, for instance, 
fish, however it cannot inhabit the microbial flora of a healthy human organism. Colonized 
individuals may not show observable symptoms; still these patients can potentially infect 
other susceptible organisms. Moreover, without appropriate therapy colonization will 
progress to clinical infection. E. meningoseptica most often infects individuals, who have 
malignant tumors, neutropaenia, diabetes, end-stage hepatic and renal disease, extensive burns 
or undergo dialysis, malnutrition and use steroids. E. meningoseptica is a common cause of 
nosocomial infections such as meningitis, sepsis, bacteremia, pneumonia, endocarditis, skin 
and soft tissue infections, wound infection, abdominal abscess, ocular infections, sinusitis, 
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bronchitis, epididymitis, dialysis-associated peritonitis and prosthesis-associated septic 
arthritis (Bloch et al., 1997; Ceyhan & Celik, 2011). 
 Neonatal meningitis. The most common disease induced by E. meningoseptica is 
neonatal meningitis, which is especially frequent in children during their first weeks of 
life. The mortality rate in meningitis patients is especially high, reaching up to 57%. 
Moreover, after infection several postinfectious abnormalities are detected, including 
brain abscesses, hydrocephalus, deafness and developmental delay. 
 Bacteremia. Second most common disease associated with E. meningoseptica is 
bacteremia, where bacteria get into the blood circulatory system. Bacteremia may arise 
as a complication of another disease (meningitis), after surgery or due to foreign 
bodies (catheters) in blood vessels. As a consequence it may initiate another infection, 
for instance, sepsis (Ceyhan & Celik, 2011). 
 Pneumonia is another E. meningoseptica caused disease, occurring mainly in 
premature infants. Similar to bacteremia it is rapidly transmitted and frequently occurs 
as outbreak (Hoque et al., 2001). 
Several infections, such as cellulitis, septic arthritis, community-acquired respiratory tract 
infection, keratitis and bacteremia were detected not only in immune-compromised patients, 
but also in healthy individuals (Steinberg, 2000). 
 
1.1.3. Antibiotic resistance 
Throughout the history bacterial ability to adapt to different environmental changes and resist 
various medications has been a serious challenge for scientists. Elizabethkingia are 
ubiquitous, multidrug resistant pathogens, therefore the right choice of antibiotics for the 
therapy is crucial. Poor treatment outcome and as a result the progression of infection usually 
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arise from the use of inactive or inappropriate bacterial agents against strains, which have 
highly specific resistance. Patterns and mechanisms of E. meningoseptica resistance are quite 
unusual and still poorly investigated. It is known so far that E. meningoseptica is resistant to 
various types of drugs, and particularly to β-lactams as resistance to β-lactams is 
chromosome-encoded. It produces 2 classes of β-lactamases – A or extended-spectrum β-
lactamases and B or metallo-β-lactamases. The second group is responsible for the resistance 
to carbapenems that are extensively employed in treatment of infections induced by multidrug 
resistant Gram-negative microorganisms (Ceyhan & Celik, 2011). E. meningoseptica is the 
only bacterium, which has two types of metallo-β-lactamases – BlaB and GOB (Bellais et al., 
2000). 
In many cases E. meningoseptica is resistant to certain antimicrobial agents, which are 
employed in meningitis therapy, including polymyxins, aminoglycosides (such as gentamicin, 
streptomycin) penicillin, ampicillin and chloramphenicol. Bacterium is also resistant to 
tetracyclines, erythromycin, linezolid, clindamycin and vancomycin (several strains are 
intermediately susceptible to the last two). E. meningoseptica appears to be the most sensitive 
to the following drugs: minocycline, rifampicin and quinolones (Krieg, 2006). 
 
1.1.4. Genetics & genomics 
Information about the genetics and genomics of E. meningoseptica is very scarce. Some 
studies were conducted on DNA-DNA hybridization to determine the relatedness of E. 
meningoseptica to other species. GC content of the bacteria was also determined (being about 
37%; Krieg, 2006) and several reports were investigating functions and properties of single 
genes (such as BlaB and GOB, which are responsible for the resistance to β-lactams; gyrB, 
which is also responsible for the resistance). All these investigations were accomplished for 
phylogenetic and taxonomic purposes or for the molecular typing of particular strains. 
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However, any further information about the genome structure, size, genes (their function and 
location) within the genome is not available. Nevertheless, genetic manipulation structures 
established for Flavobacterium johnsoniae including the gene transfer system, selectable 
marker system, suicide vector system and transposons were also successfully applied on E. 
meningoseptica (Dworkin et al., 2006). 
It is important to note that no plasmid has been discovered in genera of Elizabethkingia 
(Holmes & Owen, 1981). Therefore, it can be concluded that the resistance to various 
antibiotics is most likely chromosome-encoded (Dworkin et al., 2006). 
 
1.2. Pseudomonas aeruginosa 
1.2.1. Biology and distribution 
Pseudomonas genus mostly includes environmental saprotrophs, and the only species that can 
induce severe human diseases is Pseudomonas aeruginosa (Mathee et al., 2008). P. 
aeruginosa is a gram-negative, rod-shaped bacterium well known for its blue-green coloration 
created while cultured (Lister et al., 2009). It is asporogenous, monoflagellated 
microorganism, which demonstrates high nutritional flexibility and adaptability (Lederberg et 
al., 2000). P. aeruginosa is considered as aerobic organism, however can be anaerobic in the 
presence of suitable substrate. This species can live in various environments such as soil, 
marshes and coastal marine habitats, as well as be present on plant and animal tissues 
(Hardalo & Edberg, 1997). It can also form biofilms in humid biotopes, for instance, rocks 
and soil (Costerton et al., 1999). 
The ability of P. aeruginosa to catabolize a variety of organic complexes, for instance, 
bacteriostatic benzoate makes this bacterium ubiquitous and highly persistent (Lederberg et 
al., 2000). As all opportunistic pathogens it rarely causes diseases in healthy organisms, 
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however individuals with compromised immune system are very likely to develop the 
infection. It is also one of the most common opportunistic pathogens in hospitals, responsible 
for a quite high mortality (40 – 60%; Fick, 1993). In medical care units P. aeruginosa is often 
found on therapy equipment, antiseptics, soap, sinks, mops, medicines, as well as in 
physiotherapy and hydrotherapy pools. Apart from hospitals is can be also present in public 
swimming pools, whirlpools, hot tubs, contact lens solution, home humidifiers, soil, 
rhizosphere and various food products including vegetables (Pollack, 1995). 
 
1.2.2. Clinical picture 
Pseudomonas aeruginosa very rarely is a part of the normal microflora in human organism. It 
can be present in different tissues at a small percentage (0-6.6%); however during hospital 
treatments colonization may be even higher than 50% (Pollack, 1995). Patients with trauma, 
for instance, burns, or immunocompromised individuals (with cystic fibrosis, cancer) have 
higher risks to be infected by Pseudomonas. In spite of high abundance of this bacterium in 
the environment almost all severe infections associated with P. aeruginosa are predominantly 
acquired during hospitalization (Lister et al., 2009). Previous studies indicated that P. 
aeruginosa is the second most common pathogen isolated from the intensive care unit patients 
in Europe. It is identified approximately in 30% of pneumonia cases, 19% of urinary tract 
infection and 10% of bloodstream infection cases (Spencer, 1996). 
P. aeruginosa can target different organs and tissues of the human body and subsequently 
cause various types of infection. 
 Eye infections: Involve the damage of cornea mostly by contact lenses, and bacteria 
get into the eye as a result of injury. 
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 Ear infections: Outer ear canal infection occurs when water remains in the ear after 
swimming. It can progress to malignant otitis externa, invading deeper structures of 
the ear.  
 Chronic respiratory infections: Predominantly develop in patients with pulmonary 
diseases such as cystic fibrosis and lead to rapid decrease in lung function. Lung 
infections can also develop in case of bronchiectasis and obstructive pulmonary 
disease. 
 Hospital-acquired pneumonia: Widely spread disease, which in many cases is 
associated with P. aeruginosa, particularly in mechanically ventilated patients. It is 
characterized by a high number of deaths. 
 Urinary tract infections: One of the most common types of infection caused by P. 
aeruginosa. Can develop after surgery or due to a foreign body in urinary tract. 
 Bloodstream infections: Characterized by nodular skin lesions, and caused mainly by 
P. aeruginosa. 
 Skin and soft tissue infections: Can be acquired in hot tubs through softened skin and 
lead to folliculitis. Patients with severe burns are at a particular risk of infection as P. 
aeruginosa very often colonizes wounded skin (Hauser & Ozer, 2011) 
 
1.2.3. Antibiotic resistance 
P. aeruginosa is a highly resistant, problematic pathogen acquired in community or hospitals 
(Micek et al., 2005). Due to P. aeruginosa ability to resist numerous types of drugs as well as 
to create resistance even during the therapy, it is difficult to choose appropriate medications. 
Diseases induced by these multidrug resistant bacteria are associated with high morbidity and 
mortality rates, often involve surgeries, prolong hospital stay and chronic care, and increase 
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the cost of treatment (Aloush et al., 2006). Even more complicated clinical cases arise if the 
bacterial resistance is formed during the therapy (Dimatatac et al., 2003). 
P. aeruginosa can develop multidrug resistance through several pathways: 
o Through the obtaining of multiple imported resistance on mobile genetic components 
(for instance, plasmids), 
o Through the mix of imported and chromosome encoded resistance, 
o Through multiple modifications in chromosomal material over time 
o And/or through a single mutation, which induces an overexpression of a multidrug 
resistance mechanism (for example, efflux pump). 
Each resistance mechanism influences different types of drugs therefore can considerably 
restrain antibiotic selection possibilities and complicate the therapy of severe infections. Thus, 
for instance, imported resistance affects β-lactams and aminoglycosides, but not 
fluoroquinolones. In the case of β-lactams P. aeruginosa produces β-lactamases (for example, 
penicillinases) that inactivate β-lactams and consequently limit efficacy of the drug. On the 
contrary chromosome encoded resistance influences mainly fluoroquinolones (Lister et al., 
2009). As well as imported resistance chromosome encoded resistance mechanisms vary. 
These can include aminoglycoside- inactivating enzymes (Poole, 2005) and D oxacillinases 
(Girlich et al., 2004). 
The external membrane of gram-negative bacterium also contributes to its resistance. The 
membrane serves as a semipermeable barrier that slows down the diffusion of many 
antibacterial agents. In comparison to E. coli the external membrane of P. aeruginosa is much 
harder to penetrate. Nevertheless, to stay alive, it is important for the bacterium to receive 
nutrients, what is achieved using a group of water-filled protein channels – porins. These 
porins are key elements in the transport of sugars, amino acids, phosphates, divalent cations, 
and siderophores (Hancock & Brinkman, 2002). The loss of certain porin, however, initiates a 
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decline in membrane permeability, consequently decreasing effectiveness of antibiotics. 
Besides the loss of porins, decrease in drug accumulation is also accomplished actively 
exporting antibiotics from the cell by membrane-associated pumps – efflux pumps. All 
mentioned resistance strategies and, moreover, the ability to coregulate resistance 
mechanisms makes P. aeruginosa versatile and hardly curable pathogen, which still 
challenges therapeutic schemes (Lister et al., 2009). 
 
1.2.4. Genetics & genomics 
The genome of P. aeruginosa is noticeably larger than many other bacterial genomes 
sequenced so far. It consists of a single circular chromosome – 6.3 million base pairs (Mbp) 
for PAO1 strain (Stover et al., 2000) and with approximately 66% GC content. There are 
5,570 predicted open reading frames (ORFs) within PAO1 genome, and it is almost as 
complex as the genome of the primitive eukaryote Saccharomyces cerevisiae (Ball et al., 
2000). The majority of P. aeruginosa gene encoded products can be allocated into 3 
functional groups:  putative enzymes, transcriptional regulators and transporters of small 
molecules. 
Amongst all bacterial genomes sequenced, P. aeruginosa genome appears to have the largest 
amount of predicted regulatory genes. Previous study identified about 468 genes which have 
similar characteristics to transcriptional regulators or environmental sensors (Stover et al., 
2000).  Following these results it can be concluded that around 8.4% of P. aeruginosa genes 
participate in regulation what is far more than in any other bacterial species. Moreover, the 
overexpression of transcriptional regulators such as two-component regulatory system 
proteins or sensor-response regulator hybrids allows the organism rapidly adapt to the 
changing environment. 
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The genes that encode outer membrane proteins are very important as they play a special role 
in antibiotic transport and export of extracellular virulence factors, as well as in anchoring the 
structures that facilitate adhesion and mobility of the cell. In P. aeruginosa the number of 
predicted genes that encode outer membrane proteins is particularly large (150, predicted by 
Stover et al., 2000). Furthermore, in cytoplasmic membrane P. aeruginosa has a variety of 
membrane transport systems, from which more than a half are responsible for the import of 
nutrients and other compounds. 
Intrinsic resistance of P. aeruginosa to a range of drugs arises mostly from its external 
membrane permeability and active efflux of antibiotics (Hancock, 1998). Previous studies 
indicated that P. aeruginosa has four multidrug efflux systems, and all of them are a part of 
the resistance-nodulation-cell division family (Westbrock-Wadman et al., 1999; Nikaido, 
1998). Furthermore, P. aeruginosa was reported to have the most intricate chemosensory 
system in comparison to other bacteria. It was found that there are 4 loci, which most likely 
encode signal transduction in chemotaxis. First locus in its structure resembles the locus of 
Salmonella typhimurium, which is responsible for sensoring chemoattractants (Stock & 
Surette, 1996), while second is similar to the locus of Rhodobacter sphaeroides (Armitage & 
Schmitt, 1997). The other two loci have similarities with the genes of E. coli and gliding 
bacterium, Myxococcus xanthus (McBride et al., 1989; Stover et al., 2000). 
 
1.3.  Escherichia coli 
Escherichia coli is a Gram-negative rod-shaped bacterium and the most intensively studied 
prokaryote, used as a model organism in various scientific areas. Bacterium is a part of 
normal gut microflora in endothermic organisms including humans. However, several 
serotypes are serious human pathogens, often associated with food poisoning and 
contamination; these include enteropathogenic, enteroaggregative, enterotoxigenic, 
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enteroinvasive and Shiga toxin-producing E. coli. These strains are usually multidrug resistant 
and can cause outbreaks of severe infections including uremic syndrome (Suma et al., 2011) 
and meningitis (Lu et al., 2011) as well as can complicate the disease such as inflammatory 
bowel disease (Crohn‘s disease; Miquel et al., 2010). One of the examples of multidrug-
resistant E. coli includes the most recent outbreak in Germany caused by O104:H4 strain in 
2011. This Shiga-toxin producing strain (genome size – 5.44 Mb) induced hemolytic–uremic 
syndrome, described by the acute renal failure, haemolytic anaemia, thrombocytopenia and 
bloody diarrhoea (Frank et al., 2011). The strain was characterised as enteroaggregative, 
Shiga toxin-producing and contained a plasmid encoding extended-spectrum β-lactamase 
(Grad et al., 2012) and resistance to cephalosporins and fluoroquinolones (Frank et al., 2011). 
In current study E. coli (O104:H4 strain) will be used in Nextera optimization step as 
organism with average GC and in subsequent steps (Mate Pair sequencing and annotation) as 
a control organism. 
 
1.4. Genome sequencing 
1.4.1. High-throughput sequencing 
Being a very common technique nowadays, sequencing allows user to decode the DNA 
sequence of a targeted organism. Following capillary sequencing methods, which rely on 
Sanger sequencing (Sanger et al, 1977), Next-generation or High-throughput sequencing 
(HTS) technology was recently developed. Unlike Sanger sequencing, which uses chain-
termination principle, High-throughput sequencing employs highly parallelized processes, 
permitting to sequence thousands or millions of molecules at the same time. The most 
commonly used types of HTS are 454 pyrosequencing (Life Sciences, now Roche), which 
involves the detection of single nucleotides incorporated into DNA template employing 
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luciferase, SOLiD sequencing (Life Technologies), which employs special ligation of 
constant-length oligonucleotides and Illumina sequencing (Soon et al., 2013). 
The SBS (sequencing by synthesis) technique, designed by ‗Manteia Predictive 
Medicine S.A.‘ in late 1996 and owned by Illumina from 2006, is one of the most widespread 
and effective next-generation sequencing methods. TruSeq sequencing employs highly 
parallel sequencing based on reversible terminator method that allows recognition of single 
bases as soon as they incorporate into developing DNA strands. Each time when dNTP is 
incorporated the fluorescent terminator is imaged and further removed to enable another base 
integration. The data of this base-by-base sequencing is highly precise and has a high 
potential to be applied in many other research areas. 
 
1.4.2. Whole-genome sequencing advantages and applications 
The greatest benefit of whole-genome sequencing is in yielding the entire available DNA 
information of an isolate in just one simple step after culture. As a result all the data required 
for diagnostic and typing will be obtained, however the interpretation of this data is not 
always obvious. Genome sequence also contains a huge amount of additional information that 
cannot be obtained with routine techniques, offering the perspective of large-scale studies into 
bacterial genotype–phenotype relations. 
In clinical microbiology whole-genome sequencing can be even more beneficial. The 
introduction of sequencing into clinical microbiology is notably simplified by genetic 
characteristics of bacterial organisms. In comparison to eukaryotes, bacterial genomes are 
quite small (2-6 Mb), and mostly represented by one haploid chromosome. Nevertheless, they 
are more diverse than the genomes of eukaryotes, as may contain dispensable elements (for 
instance, plasmids), which are not present in all members of the species (Didelot et al., 2012). 
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Theoretically, the genome sequence of a pathogen holds almost all information, which is 
essential to develop the treatment and establish public health measures. Moreover, fast and 
low-cost sequencing of a whole genome will most likely replace complex multistep 
techniques, which are now employed in characterization of isolated pathogens (Relman, 
2011). However, it is still a challenge for the modern microbiology, which can be overcome 
only if the genomic knowledge and analytical techniques will allow extracting and 
interpreting the existing data appropriately. Furthermore, for successful technique 
introduction into clinical microbiology as a routine method, special attention should be paid 
when validating genotypic prediction of phenotype and especially for bacterial resistance 
studies (Didelot et al., 2012). 
Whole-genome sequencing can be used in various research areas: 
 Species identification is a very important stage of infection management and 
pathogen tracking. Taxonomic methods employed now rely on using the collection of 
different strain kinds as a standard, what in whole-genome sequencing can be 
substituted by ―reference sequence‖, which is compared to isolate sequence. 
 Drug resistance prediction. Using whole-genome sequencing tools the prediction of 
resistance phenotype (by the identification of resistance genes) should be possible. 
This will allow rapid selection of antibiotic therapy, however genetic determinants of 
drug resistance should be constant across the phenotypes (successful examples include 
S. aureus (McAdam et al., 2011), Vibrio cholera (Mutreja et al., 2011) and 
Burkholderia dolosa (Lieberman et al., 2011)). In combination with extensively used 
PCR techniques whole-genome sequencing can improve the resistance prediction 
results.  Moreover, computational approach may be more sensitive than use of PCR 
primers (Didelot et al., 2012). 
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 Identification of virulence factors. It is essential to improve the knowledge of 
genetic mechanisms of virulence, as they are extensively studied, but not well-
understood. Sequencing can provide all of the information about virulence factors in a 
single step, also opening a horizon for new virulence factor discovery employing the 
connection of isolate data with outcome data from the patient (example includes 
identification of Shiga toxin in O104:H4 strain of E. coli; Rasko et al., 2011). 
 Outbreak detection and surveillance. Sequencing has a potential to deliver well-
resolved, precise, high-quality data regarding isolate relatedness. Whole-genome 
sequencing of various organisms (for instance, Chlamydia trachomatis; Harris et al., 
2012) already revealed limitations of existing clinical typing methods, which are used 
for identifying phylogenetic relationships. Latest studies also indicated that 
sequencing can be very useful in outbreak source detection and in transmission route 
identification within societies and medical units (Koser et al., 2012; Eyre et al., 2012; 
Didelot et al., 2012). 
 
1.4.3. Fragments, pairs and mate-pairs 
Basic sequencing method, which relies on chain-termination principle, is still widely used 
nowadays. However, it can decode only short DNA fragments (1,000-2,000 base pairs (bp)), 
which is an important limitation as the most simple viral genome already consists of more 
than 10,000 bp, bacterial genomes are even larger – several millions bp, and mammalian 
genomes consist of billions of base pairs. A relatively new principle – shotgun sequencing 
was developed as a solution for this problem. The principle is based on shearing the DNA 
sequence into multiple short fragments, followed by sequencing of fragment ends. Produced 
sequences are then joined together or assembled by a computer program – assembler (CBCB, 
cited June 2013). 
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The underlying principle of the assembler is based on assumption that two sequence reads, 
which contain same sequence of nucleotides, have the same location in the genome. The data 
employed in genome assembling consist of single and paired reads. Single reads are originally 
sequenced small DNA fragments. Overlapping these sequences the programme can join them 
together, creating a contiguous (ungapped) sequence or contig (Baker, 2012); however it can 
create an assembly only if sequences are able to cover the genome 8-10 times. This 
oversampling of the genome is known as coverage. A perfect assembly program should 
generate only one contig for every sequenced chromosome. Nevertheless, in almost all cases a 
number of contigs are created due to unsequenced parts of the genome and occurrence of 
multiple almost-indistinguishable copies of genome regions so called repeats, which can 
cause errors (CBCB, cited June 2013). 
Paired reads have similar sizes to single reads, however, they are originated from either 5‘ or 
3‘ end of DNA fragments, which are too large for straight-through sequencing (Baker, 2012). 
Paired-end sequencing allows obtaining reads from DNA fragments in both forward and 
reverse directions. If the additional information, for instance mate-pairs, is available, 
generated contigs can be ordered and oriented along a chromosome, producing scaffolds 
(ordered contigs with estimated gaps in between). Mate-pair fragments are much larger (2-5 
kb) than fragments obtained with original paired-end sequencing and contain junction adapter, 
therefore permitting estimation of gaps between contigs and orientation of contigs (Nagarajan 
et al., 2010). 
 
1.4.4. De novo assembly 
As the outcome of high-throughput sequencing is a variety of short (30 to 100 bp) 
overlapping reads from the desired genome, the initial step of the analysis is assembling the 
reads into longer genome fragments (Nielsen et al., 2011). There are two methods to 
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accomplish that: to create a ‗reference based assembly‘ or to produce de novo assembly. The 
first approach compares the reads to an available reference genome (sequence of which is 
already determined) to see which regions are alike and which different. This method is very 
efficient, when determining genetic diversity in isolates with available high-quality reference 
genome. Disadvantages of such method are: any fragment, which is not present in the 
reference genome, will not be assembled; mapping accuracy decreases, if the target and 
reference genomes are not closely related. Therefore, genome assembling without the 
reference or de novo assembly (carried out by programs Newbler (Chaisson & Pevzner, 2008) 
or Velvet (Zerbino & Birney, 2008)) is of a particular interest nowadays. De novo approach 
does not possess previously mentioned problems: the whole genome is assembled and quality 
is not reference-dependant (Didelot et al., 2012). Moreover, de novo assembly can provide 
more information, when sequencing a new organism or a new strain of well-known species 
(Loman et al., 2012). De novo assembly, however, is complicated by its result, which gives 
tens or hundreds of contigs. Due to the complexity of the target genome and the presence of 
repetitive fragments, which can be homologous to many genome regions, further assembling 
can become even more difficult or almost impossible (Didelot et al., 2012). 
 
1.4.5. Genome finishing 
Prior the invention of HTS, it took several weeks to obtain a draft sequence of a particular 
genome, while to finish the whole genome (obtain a complete sequence) many month or even 
years of intensive (and expensive) experiments were required. Development of HTS started a 
new era of genome finishing, where a single machine can produce draft assemblies for 5 
bacterial genomes in just few days. Finished or nearly-finished genome is a desirable outcome 
that allows a scientist to acquire broader and richer information for genomic analysis. To 
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simplify the finishing process draft assemblies can be combined with additional sequence and 
map-based information (Nagarajan et al., 2010). 
There are two main limitations of shotgun sequencing – genome fragmentation (due to 
repeats) and errors (due to sequencing artefacts or improper reconstruction of repeats), which 
finishing process aims to conquer. Finishing, therefore, consists of two main phases: gap 
closure, and assembly validation and enhancement. First phase includes determination of the 
sequence, which fits into the gap between adjacent contigs employing directed-PCR and 
primer-walking approaches. With the presence of mate-pair data contig linkage can be quite 
easily determined and gaps can be closed. However, contigs, for which mate-pairs cannot 
provide linkage information, require time-consuming, expensive and various-combination 
PCR (Tettelin et al., 1999). The second finishing phase – validation and enhancement – 
targets to correct errors in the assembly. These errors can be single-base, for instance, if a 
base is mis-called, and large-scale, for example, mis-assemblies due to repetitive regions. 
Nevertheless, errors caused by repeats can be fixed using targeted PCR aimed to correct the 
adjacency of the assembled contigs (Nagarajan et al., 2010). 
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1.5. Aim and objectives 
This study aims to finish or start finishing the genomes of Pseudomonas aeruginosa and 
Elizabethkingia meningoseptica as well as to optimize Nextera protocols for bacteria with 
different GC. 
The objectives are: 
 To optimize Nextera XT protocol for bacteria with different GC content using 
Elizabethkingia meningoseptica, Escherichia coli and Pseudomonas aeruginosa, and 
obtain 450 bp or longer fragments; 
 To join sequencing obtained fragments into contigs; 
 To perform Mate-pair sequencing employing Elizabethkingia meningoseptica, 
Escherichia coli, and Pseudomonas aeruginosa 901 and 950 and yield long sequences 
(2-5 kb); 
 To join contigs into scaffolds; 
 To finish the genome employing PCR and Sanger sequencing; 
 To annotate the genomes of bacteria. 
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2. Materials and Methods 
 
2.1. Sample preparation for Nextera testing 
2.1.1. Isolates 
Elizabethkingia meningoseptica strain 501 was isolated in Birmingham Hospital from blood 
of 60 year old patient with acute leukaemia. Susceptibility tests showed that specimen is 
resistant to piperacillin/tazobactam, ceftazidime, meropenem and aztreonam, while sensitive 
to amikacin and ciprofloxacin, and variable to gentamicin. Pseudomonas aeruginosa ST395 
specimen 901 was isolated from water samples (in hospital shower) and specimen 905 was 
sampled besides Pseudomonas-positive patient in Birmingham hospital. Escherichia coli 
strain O104:H4 specimen 1218_280 was received from London Health Protection agency 
(extracted from patient, who arrived to UK from Germany, carrying Shiga toxin-producing E. 
coli). DNA from Elizabethkingia meningoseptica 501 and Pseudomonas aeruginosa ST395 
was extracted in Birmingham Hospital. 
 
2.1.2. Parameter optimization for bacteria with different GC  
In order to optimize Nextera protocols for bacteria with different GC content 3 bacteria were 
involved in the experiment: Pseudomonas aeruginosa ST395 with high GC content (~65%), 
E. coli O104:H4 with medium GC (~50%) and Elizabethkingia meningoseptica 501 with low 
GC (~38%). A stock solution of 4 ng/µl was firstly obtained diluting the original sample in 
elution buffer (EB; QIAGEN). Further concentrations were obtained diluting the appropriate 
amount of stock solution in EB. Four concentrations of input DNA were used: 0.1, 0.2, 0.3, 
and 0.4 ng/µl, for every species. Reaction times in thermocycler during tagmentation process 
were also optimized: 3, 5 and 7 minutes. 
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2.2. Fluorometer 
To determine original and diluted sample concentrations high sensitivity (HS) dsDNA assay 
was carried out. High sensitivity Quant-iT™ dsDNA assay kit (Molecular Probes, Life 
technologies) was used to perform precise determination of concentrations. After kit reagents 
reached room temperature, working solution was prepared by diluting HS reagent in HS 
buffer (1:200). It was transferred to the Qubit assay tubes (Molecular Probes, Life 
technologies), both standard and sample tubes. Standard 1 (λ dsDNA High sensitivity 
standard 0 ng/ µl) and 2 (λ dsDNA High sensitivity standard 10 ng/ µl) were then added to 
standard tubes (1:20 in working solution). After Qubit flourometer (Invitrogen) was 
programmed to run dsDNA HS assay, it was calibrated using standards. Next, samples were 
added to sample tubes (1:200 in working solution) and quantified measuring the fluorescence 
at excitation/emission 500/520. 
 
2.3. Nextera XT sequencing 
The Nextera XT Sample preparation kit allows preparing isolated DNA for sequencing on 
various Illumina sequencing machines. All reagents used in Nextera XT experiments were 
purchased from Illumina Inc., unless stated otherwise (Nextera XT protocol – Illumina, 
2012a). 
Figure.2.1. Nextera XT workflow. Adopted from Illumina protocol (Illumina, 2012a). 
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2.3.1. DNA tagmentation 
First, all the reagents were thawed, vortexed (Vortex genie, Scientific Industries Inc.) and 
briefly centrifuged in a microcentrifuge (Eppendorf, 5417C). Then TD buffer (Tagment DNA 
Buffer) was added to all used wells of 96-well PCR plate (BIO-RAD Laboratories Inc.). Input 
DNA (0.1, 0.2, 0.3, and 0.4 ng/µl) was then transferred to the plate, and ATM (Amplicon 
Tagment Mix) was added to the mix. This solution was gently mixed, the plate was covered 
with Microseal (seal ‗B‘, BIO-RAD Laboratories Inc.) and centrifuged (Eppendorf, 
Centrifuge 5810R) at 280 xg (x gravitation or rcf) for 1 minute. Next the plate was transferred 
to thermocycler (Eppendorf, Mastercycler Gradient) and following thermocycling conditions 
were set: 
 55 ºC for 3, 5 or 7 minutes 
 Hold at 10 ºC. 
After samples reached 10 ºC Microseal was removed and NT (Neutralize Tagment Buffer) 
was added. Then plate was covered again, centrifuged at 280 xg for 1 minute and incubated at 
room temperature for 5 minutes. 
 
2.3.2. PCR amplification 
NPM (Nextera PCR Master Mix) was added to each well of the plate from previous step. 
Then the unique combination of 2 index primers (one N7XX and one S5XX primer type) was 
added to each well. The solution was gently mixed, and the plate was sealed with Microseal 
(seal ‗A‘, BIO-RAD Laboratories Inc.) and centrifuged at 280 xg for 1 minute. PCR 
amplification was then carried out using the following thermocycling conditions: 
 72 ºC for 3 minutes 
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 95 ºC for 30 seconds 
 12 cycles of: 
o 95 ºC for 10 seconds 
o 55 ºC for 30 seconds 
o 72 ºC for 30 seconds 
 72 ºC for 5 minutes 
 Hold at 10 ºC. 
After amplification samples were either cleaned-up immediately or stored in thermocycler at 
10 ºC overnight. 
 
2.3.3. PCR clean-up 
PCR clean-up was performed to purify DNA library and remove very short fragments from 
the samples. First, AMPure XP beads (Agencourt, Beckman Coulter Inc.; 0.5x) were added to 
PCR plate and mixed with the sample. The plate was incubated at room temperature for 5 
minutes and placed on a magnetic stand (DynaMag™ - 96 Side skirted, Life Technologies 
AS) for 2 minutes. When the supernatant appeared to be clear it was removed from wells. 
Then beads were washed with 80% ethanol (diluted in distilled H2O; Fisher Scientific), the 
plate was incubated at room temperature for 30 seconds and supernatant was discarded. 
Ethanol wash was then performed for the second time. While the plate still remained on the 
magnetic stand, beads were air-dried for 15 minutes. Next, the plate was removed from the 
stand and RSB (Resuspension Buffer) was added to each well. After mixing the solution was 
incubated at room temperature for 2 minutes. The plate was then placed on the magnetic stand 
for 2 minutes, and cleared supernatant was transferred to a new plate. After clean-up samples 
were either normalized immediately or stored at -25 ºC for 2-3 days. 
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2.3.4. Library normalization 
Normalization process was carried out in order to ensure that all samples were equally 
represented in the library. In a separate 15 ml Falcon tube (BD Falcon™) LNA1 (Library 
Normalization Additives 1) was mixed with LNB1 (Library Normalization Beads 1) and this 
mix was then added to each well of the plate containing DNA from previous step. Plate was 
covered with Microseal B and shaken on a microplate shaker (Eppendorf, Thermomixer 
comfort, Hamburg, Germany) at 1,800 rpm for 30 minutes. Next, the plate was positioned on 
the magnetic stand for 2 minutes. After supernatant was clear, it was removed. Plate was 
removed from the stand and washed with LNW1 (Library Normalization Wash 1) twice. 
NaOH 0.1N (10M Sodium hydroxide solution, Sigma-Aldrich; diluted 1:100) was then added 
for sample elution. Plate was then placed on the magnetic stand for 2 minutes. LNS1 (Library 
Normalization Storage Buffer 1) was then added to a new storage plate and clear supernatant 
was transferred from the previous plate. The plate now containing normalized samples was 
sealed and centrifuged at 1,000 xg for 1 minute. The plate was stored at -25 ºC or pooled 
straightaway. 
 
2.3.5. Library pooling 
The heat block (Eppendorf, Thermomixer comfort, 0 rpm) was set to 96 ºC and MiSeq 
reagent cartridge was thawed at room temperature. Normalized plate was centrifuged at 1,000 
xg for 1 minute and samples were mixed. The libraries from each well were combined in one 
Eppendorf tube (1.7 ml, Sarstedt) labelled PAL (Pooled Amplicon Library) and mixed. The 
content of PAL was then transferred into another tube (DAL, Diluted Amplicon Library) 
containing HT1 (Hybridization buffer) and mixed again. After DAL was incubated at 96 ºC 
for 2 minutes, inverted and immediately placed in ice-water bath for 5 minutes. Finally, DAL 
was loaded into MiSeq reagent cartridge (Well 17 - Load Sample reservoir). 
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2.3.6. MiSeq Sequencing 
After loading Amplicon Library into MiSeq reagent cartridge, sequencing run was set, 
following the directions on the screen. A flow cell (Single-use PE flow cell) provided in the 
kit was washed in dH2O and wiped with methanol (Absolute, Fisher Scientific) prior loading 
into Flow Cell Stage. The reagents were loaded into Reagent Compartment: first, the PR2 
bottle (Incorporation Buffer) and empty waste bottle, and after the reagent cartridge. When 
the software confirmed that all components and conditions were correctly set, sequencing (24 
hours) was performed. 
 
2.4. Bioanalyzer 
2.4.1. High Sensitivity assay for Nextera XT 
To perform a quality control of DNA fragment sizes High Sensitivity DNA assay was carried 
out employing Agilent 2100 Bioanalyzer on different sequencing stages (after PCR 
amplification and PCR clean-up). The electrodes of bioanalyzer were washed with dH2O prior 
the run. High Sensitivity DNA Kit (Agilent Technologies) was used in the assay. First, all 
reagents were equilibrated to room temperature (30 minutes) and vortexed. Then, HS DNA 
dye concentrate was added to gel matrix and mixed well. The complete mix was transferred to 
spin filter tube, vortexed until appeared homogenous and centrifuged (Mikro 22 Centrifuge, 
Hettich Zentrifugen) for 10 minutes at 6000 rpm. The filter was removed, and the gel-dye was 
used in subsequent steps. 
High Sensitivity DNA chip (Agilent Technologies) was placed on the chip priming station 
(Agilent Technologies), and gel-dye was added to the well marked G. After pressurising, gel-
dye was added to 3 wells marked G. HS DNA marker was inserted in all the remaining wells, 
ladder was added to ladder well, and samples were added to 11 remaining wells. DNA chip 
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was then vortexed (Vortexer Ika Works) for 1 minute at 2400 rpm and inserted into 
Bioanalyzer. High Sensitivity DNA assay was selected in 2100 Expert software, and the run 
was performed (Agilent Technologies, 2009). 
 
2.4.2. DNA 12000 assay for Nextera Mate pair sequencing 
Quality control of mate pair fragments was performed at different sequencing stages (after 
AMPure Purification of Strand Displacement Reaction and during validation step) using 
Agilent 2100 Bioanalyzer 12000 assay kit (Agilent Technologies). The gel-dye was prepared 
as in HS assay. 12000 DNA chip (Agilent Technologies) was used in the assay. Gel-dye was 
added to the well marked G, pressurized, and again added to 2 wells marked G. The marker 
was inserted in all the remaining wells, ladder was added to ladder well, and samples were 
added to 12 remaining wells. DNA chip was then inserted into Bioanalyzer. 12000 DNA 
assay was carried out using 2100 Expert software (Agilent Technologies, 2007). 
 
2.5. Nextera Mate Pair sequencing 
Nextera Mate Pair sample preparation was performed using gel-free protocol as it is shorter, 
more robust, yields a higher diversity of fragments, and requires less input DNA than the gel-
plus protocol. All reagents were supplied by Illumina, unless stated otherwise (Nextera Mate 
Pair protocol – Illumina, 2013). 
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Figure.2.2. Nextera Mate Pairs workflow. Adopted from Illumina protocol (Illumina, 2013). 
 
2.5.1. Tagmentation 
First, the reaction components were added to the eppendorf tube in following order: Genomic 
DNA (1 μg), dH2O, Mate Pair Tagment Buffer and Tagment Enzyme. The tube was incubated 
at 55 ºC for 30 minutes. Then tagmentation reaction was purified employing Zymo Genomic 
DNA Clean & Concentrator™ kit (Zymo Research). Briefly, ChIP DNA Binding Buffer (2 
vol) was mixed with the samples, transferred to a Zymo-Spin IC-XL column in a collection 
tube, and mixture was centrifuged for 30 seconds at 11,000 xg. Wash step (repeated twice) 
was performed using Zymo DNA Wash Buffer (centrifugations were performed for 1 minute 
at 11,000 xg). The column was then transferred to a clean tube, and RSB (Resuspension 
Buffer) was added to elute DNA. 
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2.5.2. Strand Displacement 
Strand displacement was carried out immediately after tagmentation. Reagents were added to 
the tube with tagmented DNA in the following order: water, 10X Strand Displacement buffer, 
dNTPs and Strand Displacement Polymerase. The reaction was mixed, briefly centrifuged 
(1,200 rcf, 3-5 seconds) to collect reaction to the bottom, and the tube was incubated at 20 ºC 
for 30 minutes. 
 
2.5.3. AMPure Purification of Strand Displacement Reaction 
The reaction components were added to the strand displaced DNA from previous step in the 
following order: water and then AMPure XP Beads. The reaction was incubated at room 
temperature for 15 minutes, and the tube (centrifuged at 1,200 rcf, 3-5 seconds) was placed on 
the magnetic stand for 5 minutes. Beads were then washed in 70% ethanol (7:3 in dH2O) 
twice. After air-drying beads (15 minutes), RSB was added to elute DNA from beads. The 
tube was then briefly centrifuged, incubated at room temperature for 5 minutes and placed on 
magnetic stand for 5 minutes. The supernatant, containing purified DNA was transferred to a 
new tube. At this time point to assess the quality of the fragments, samples (diluted in dH2O – 
1:1) were examined using Bioanalyzer (1200 DNA assay). 
 
2.5.4. Circularization 
Circularization was carried out straight after the quality control (due to the gel-free protocol, 
size selection step was skipped). The following components were added to a clean eppendorf 
tube: purified DNA (500 ng), water, Circularization Buffer (10X) and Circularization Ligase. 
The reaction was mixed by inverting the tube and briefly centrifuged (1,200 rcf, 3-5 seconds). 
The tube was incubated at 30 ºC for 12-16 hours (overnight). 
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2.5.5. Exonuclease Digestion 
After overnight incubation digestion of linear DNA was performed. Exonuclease was added 
to the tube with circularized DNA from previous step, and the tube was briefly centrifuged 
(1,200 rcf, 3-5 seconds). After it was transferred to the heat block and incubated at 37 ºC for 
30 minutes. Then exonuclease was inactivated by incubation at 70 ºC for 30 minutes. Stop 
Ligation buffer was added to the tube, and the solution was mixed and briefly centrifuged. 
 
2.5.6. Circularized DNA Shearing 
After digestion DNA was shared into small fragments using Covaris AFA™ Ultrasonicator 
S2 (Covaris Inc.). Following the guidelines, the water in the instrument was de-gassed and 
pre-chilled to 3-6 ºC. The sample was transferred to Covaris glass tube, and the tube was 
capped. The subsequent parameters were applied to the Covaris programme: Intensity – 8, 
Duty Cycle/Duty Factor – 20%, Cycles per Burst – 200, Time – 40 s, Temperature – 6 ºC. 
After shearing process the sample was transferred to new eppendorf tube. 
 
2.5.7. Streptavidin Bead Binding 
Streptavidin bead binding process was performed immediately after shearing. Dynabeads M-
280 streptavidin magnetic beads (Invitrogen) were placed (in a tube) on the magnetic stand 
for 1 minute and then washed (twice) and resuspended in bead bind buffer. The complete 
beads were added to sheared DNA sample and incubated at 20 ºC for 15 minutes. The bead 
wash was then performed (on the magnetic stand, 4 times), employing a bead wash buffer. 
After removing beads from magnet, they were resuspended in RSB and placed back on the 
magnetic stand for 30 seconds. The final solution remained on the stand until the next step. 
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2.5.8. End Repair 
The following component was added to DNA (after supernatant removal) from previous step: 
end repair mix in water. The tube was then removed from magnet, and incubated at 30 ºC for 
30 minutes. After samples were centrifuged and placed on the magnetic stand for 1 minute. 
The bead wash from Streptavidin bead binding step was then performed again. 
 
2.5.9. A-Tailing 
In a clean tube A-Tailing mix was combined with water. It was then added directly to the 
beads, and the tube was then transferred to the heat block and incubated at 37 ºC for 30 
minutes. 
 
2.5.10. Adaptor Ligation 
After incubation adaptor ligation was carried out. The following ingredients were added to 
DNA from previous step: Ligation mix, water, DNA Adapter Index (AD0XX). After 
incubation (at 30 ºC for 10 minutes), Ligation Stop buffer was added to the reaction. The 
beads were briefly centrifuged and placed on the magnetic stand for 1 minute. The bead wash 
was then performed one more time. 
 
2.5.11. PCR Amplification 
The components of PCR reaction were added to the tube as follows: PCR Master Mix, PCR 
Primer Cocktail, water. After PCR reaction mix was added, and beads were transferred to 
PCR tubes (200 µl, Anachem). The subsequent thermocycling conditions were then applied: 
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 98 ºC for 30 seconds 
 10 cycles of: 
o 98 ºC for 10 seconds 
o 60 ºC for 30 seconds 
o 72 ºC for 30 seconds 
 72 ºC for 5 minutes 
 Hold at 4 ºC 
 
2.5.12. PCR Clean-Up 
AMPure beads were mixed with PCR reaction and washed with ethanol (70%) twice. Then 
RSB was added (for 5 minutes) to elute DNA from beads. Cleared supernatant (containing 
final DNA library) was then used in subsequent step. 
 
2.5.13. Library Validation and Preparation 
To evaluate library sizes and concentration, the quality control was performed at this step 
employing Bioanalyzer 1200 assay. After the concentration was calculated, libraries were 
normalized to 2nM with the Elution buffer (10mM Tris-Cl, pH 8.5 with 0.1% Tween 20). 
Library pooling for cluster generation and sequencing was then carried out: the equal amount 
of each normalized sample (2nM) was added to eppendorf tube. To prepare libraries for 
sequencing DNA was denatured using NaOH (0.2N). HT1 was then added to denatured DNA 
(8 pM final DNA concentration), and sample was loaded to MiSeq reagent cartridge (and 
sequenced on MiSeq as above). 
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2.6. Genome finishing 
2.6.1. Direct PCR 
Direct PCR was performed using Elizabethkingia meningoseptica 501 DNA sample. 
Oligonucleotides sequences - primers (design method in data analysis chapter; primer 
sequences in Appendix I) were purchased form either Alta biosciences or Sigma-Aldrich. 
MyTaq DNA polymerase and dNTPs were supplied by Bioline Ltd. 
 
2.6.1.1. Amplification 
The primers were diluted to 10 µM with dH2O. PCR amplification reaction was set in 200 µl 
PCR tubes. The components were added to PCR reaction tube in the following order (FC – 
final concentration): nuclease-free H2O, MyTaq Buffer 5x (1x FC), 25 mM dNTPs (200 µM 
FC), template DNA (0.08 ng/µl FC), Forward Primer, Reverse Primer (200 nM FC) and 500 
units MyTaq DNA Polymerase (0.025 – 0.1 units/µl FC). The reaction was centrifuged and 
subsequent thermocycling programme was set: 
 Initial denaturation: 94 ºC for 30 seconds 
 30 cycles of: 
o Denaturation: 94 ºC for 30 seconds 
o Annealing: 50-58 ºC for 30 seconds 
o Extension: 68 ºC for 1-3 minutes 
 Final Extension 68 ºC for 5 minutes 
 Hold at 15 ºC. 
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2.6.1.2. Gel electrophoresis 
Buffer: 
 TBE buffer 1x (Tris-Borate-EDTA 10x, pH 8.3, diluted with dH2O 1:10; AppliChem) 
After PCR amplification the presence of DNA products was verified using gel 
electrophoresis. First, 1.5% gel was made, mixing agarose (Multi-purpose, Bioline) with TBE 
buffer. Sybr Safe DNA gel strain (1%; Invitrogen) was then added, and the mixture was 
poured into tank (sealed with tape and with a comb). When the gel was solid TBE buffer was 
added into tank, and the comb was removed. HyperLadder 1kb (Bioline) was then added to 
the first and last well. The sample was mixed with DNA loading buffer 5x (Blue, Bioline; 1:5) 
and added to the sample wells. Electrophoresis was carried out at 100 volts for 60 minutes. 
PCR products were visualized in transilluminator (Bio-Rad, Molecular Imager Gel Doc XR) 
employing Quantity One software. 
 
2.6.2. Long Range PCR 
To obtain DNA products larger than 6 kb (original Taq PCR limit) Long range PCR was 
carried out. Accu Taq LA DNA Polymarase kit (Sigma-Aldrich) was used in the experiment. 
The following reagents were added to the reaction tube (200 µl PCR): nuclease-free H2O, LA 
Buffer 10x (1x FC), dNTPs (500 µM FC), template DNA (4 ng/µl FC), DMSO (2% FC), 
Forward and Reverse Primer (400 nM FC), and Taq LA Polymerase (0.05 units/µl FC). The 
subsequent thermocycling conditions were used: 
 Initial denaturation: 98 ºC for 30 seconds 
 30 cycles of: 
o Denaturation: 94 ºC for 15 seconds 
o Annealing: 55 ºC for 20 seconds 
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o Extension: 68 ºC for 10 minutes 
 Final Extension 68 ºC for 10 minutes 
 Hold at 15 ºC. 
Gel electrophoresis and visualization was performed as above. PCR products were finally 
sequenced employing Sanger sequencing. 
 
2.7. Data analysis 
The data from Nextera XT and Mate pair sequencing was analysed using Galaxy/Tron 
software. The reads were aligned using Bowtie 2 alignments to a reference genome. 
Sequencing alignment data features and properties (such as fragment insert sizes) were 
visualised employing Qualimap v0.7.1. MIRA (Mimicking Intelligent Read Assembly) 
software was used to assemble the reads into contiguous sequences or contigs. MIRA also 
added Hash Frequency (HAF) tags into the assembly. After the possible joints of the contigs 
were determined using Gap 5 software and a Contig connection map was created. 
Mate pair data was also used to scaffold pre-assembled contigs employing SSPACE software 
(which assess the order, distance and orientation of contigs). Tablet software was used to 
determine possible scaffold end connections employing Mate pair information. Primers for 
PCR genome finishing were designed employing Primer3 (v. 0.4.0) software. Sanger 
sequencing results were analysed using FinchTV and BLAST (Basic Local Alignment Search 
Tool). Genome annotation was obtained using RAST (Rapid Annotation using Subsystem 
Technology). Phylogenetic trees were built in snpTree1. 1 software (the programme is using 
SNPs – single nucleotide polymorphisms to construct a tree employing whole or assembled 
genomes) or using BLASTN. 
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3. Results 
 
3.1. Paired-end whole-genome sequencing (Nextera XT) 
Nextera technology is a completely new method designed to prepare nucleic acid samples for 
sequencing. Nextera XT enables preparation of sequencing-ready libraries for small genomes 
(bacteria, archaea, viruses), amplicons and plasmids. It is fastest and easiest sample 
preparation method designed, which requires ultra-low DNA input – only 1 ng. The principle 
of the Nextera XT involves transposome, which shares and tags (tagment) DNA, adding a 
special adapter during the tagmentation reaction. Then using this adaptor DNA is amplified 
employing limited-cycle PCR, which also adds index sequences on both DNA ends, required 
for cluster generation. Finally, samples are combined and denatured into single strands prior 
sequencing. 
The outcome of previous sequencing experiments (in our lab) was very short, inconsistent 
length fragments: less than the read length (250 bp). Therefore it was essential to optimize 
the parameters of DNA preparation for sequencing, such as input DNA concentration (to 
obtain longer fragments) and incubation time during tagmentation (to ensure that fragments 
are efficiently tagged and further more effectively amplified). 
 
3.1.1. Quality control (Bioanalyzer) 
To prevent sample loss or any sample preparation errors Bioanalyzer quality control was 
carried out after PCR amplification and PCR clean-up. Agilent Bioanalyzer‘s a lab on a chip 
principle employs capillary electrophoresis and utilises fluorescent dye (that binds DNA) to 
calculate the sizes and concentrations of nucleic acid fragments. 
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After PCR amplification bioanalyzer analysis showed the large range of fragments with 
different sizes (150-1500 bp; Figure 3.1 (sample 1, 2, 3) and Figure 3.2). The sample with 
concentration of 0.3 ng showed the best result as the sizes of many fragments were between 
500-1500 bp. After PCR clean-up, however, the variety of fragment sizes drastically 
decreased, leaving only desired long fragments (Figure 3.1 (sample 7, 8, 9) and Figure 3.3). 
At this step all samples showed similar results – one high peak between 600 and 2000 bp. 
 
Figure 3.1. Gel image (XT) of E. coli samples with different DNA input concentrations (0.1, 0.2, 0.3 
ng) after PCR amplification (sample 1-3) and PCR clean-up (sample 7-9). Numbers on the left show 
DNA insert sizes in base pairs (bp). DNA ladder (L) represents a mixture of DNA fragments of known 
sizes (based on that samples are aligned to the ladder). Two lines represent lower (   ) and upper (   ) 
markers – DNA fragments added to each sample, bracketing the DNA sizing analysis. Markers are the 
internal standards employed to align the ladder with the individual sample analysis. 
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Figure 3.2. Bioanalyzer summary electropherograms (XT1) of E. coli samples after PCR amplification. DNA input concentrations 1) - 0.1, 2) - 0.2 and 3) - 0.3 ng. 
Electropherogram represents Fluorescence intensity (FU) versus Size (bp). Two sharp peaks are lower (35 bp) and upper (10380 bp) markers. 
 
   
Figure 3.3. Bioanalyzer summary electropherograms (XT2) of E. coli samples after PCR clean-up. DNA input concentrations 1) - 0.1, 2) - 0.2 and 3) - 0.3 ng. 
Electropherogram represents Fluorescence intensity (FU) versus Size (bp). Two sharp peaks are lower (35 bp) and upper (10380 bp) markers.
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3.1.2. Nextera XT optimization Step 1 
During the first optimization stage different sequencing parameters (Chart 3.1) – DNA input 
concentrations (0.1, 0.2 and 0.3 ng/µl) and incubation times (3, 5, and 7 minutes), were 
applied for 3 bacteria: Pseudomonas aeruginosa ST395 specimen 901 (GC content ~65%), E. 
coli O104:H4 specimen 1218_280 (GC ~50%) and Elizabethkingia meningoseptica 501 (GC 
~38%). 
Sample 
ID 
Species Conditions Sample 
ID 
Species Conditions Sample 
ID 
Species Conditions 
1211 Ec 01ng-7mins 901-1 Pa 01ng-7mins 501-1 Em 01ng-7mins 
1218-2 Ec 02ng-7mins 901-2 Pa 02ng-7mins 501-2 Em 02ng-7mins 
1218-3 Ec 03ng-7mins 901-3 Pa 03ng-7mins 501-3 Em 03ng-7mins 
1218-4 Ec 01ng-5mins 901-4 Pa 01ng-5mins 501-4 Em 01ng-5mins 
1218-5 Ec 02ng-5mins 901-5 Pa 02ng-5mins 501-5 Em 02ng-5mins 
1218-6 Ec 03ng-5mins 901-6 Pa 03ng-5mins 501-6 Em 03ng-5mins 
1218-7 Ec 01ng-3mins 901-7 Pa 01ng-3mins 501-7 Em 01ng-3mins 
1218-8 Ec 02ng-3mins 901-8 Pa 02ng-3mins 501-8 Em 02ng-3mins 
1218-9 Ec 03ng-3mins 901-9 Pa 03ng-3mins 501-9 Em 03ng-3mins 
Chart 3.1. Sample parameters (input DNA concentrations, ng and incubation times, minutes) of the 
Optimization step 1. Ec – E. coli, Pa – P. aeruginosa, Em – E. meningoseptica. 
 
Sequencing results (forward and reverse read for each sample) were imported into Galaxy and 
aligned using Bowtie 2 to a reference genome (creating a Binary bam alignments file). Insert 
sizes for each sample were visualised employing Qualimap software. Insert size histograms 
(Chart 3.2; Appendix II) were analysed, and mean, median and mode values were 
determined for each sample. 
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1) 2)  3) 
 
4) 5) 6) 
 
7) 8) 
 
9) 
Chart 3.2. Insert size 
histograms of E. 
meningoseptica. Bars 
represent number of 
reads (y axis) at 
different insert sizes, 
bp. 1-9 show different 
sample preparation 
conditions (listed in 
Chart 3.1, column 3 in 
the same order). 
Created using 
Qualimap v0.7.1. 
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The mode insert sizes (averaged) for varying incubation times are showed in Chart 3.3. In E. 
meningoseptica samples (a) the average mode value slightly increases when incubation time 
reduces. In P. aeruginosa (b) average mode values remain almost constant. However, in E. 
coli samples (c) mode insert size reaches the highest peak at 5 minutes, but no time-specific 
trend is observed. Overall, incubation time had no considerable effect on insert sizes during 
the Optimization step 1. Therefore, 5 minutes incubation time, previously suggested in the 
Nextera XT protocol, was considered as optimum and used in the subsequent experiments. 
Chart 3.4 indicates the mode insert sizes (averaged) for different DNA input concentrations. 
A similar trend (however not highly significant) is detected in E. meningoseptica (a) and E. 
coli (c) mode insert sizes reaching the highest peak at 0.2 ng concentration. The mode insert 
size in P. aeruginosa (b) again does not change significantly (probably due to inaccurate 
pipetting). To validate these results it was considered to select broader range of concentrations 
(0.1 – 0.4 ng) and observe the insert sizes in all three bacteria with 5 minutes incubation time 
(Optimization step 2). 
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Chart 3.3. Averaged mode 
insert sizes (base pairs) at 
different incubation times 
(3, 5, 7 minutes). 
Optimization step 1. Data 
points (Δ) represent 
average values of 3 
measurements. 
a) E. meningoseptica 
(Em) mode insert sizes 
 
 
 
 
 
 
b) P. aeruginosa (Pa) 
mode insert sizes versus 
time; 
 
 
 
 
 
 
c) E. coli (Ec) mode 
insert sizes versus 
time.versus time; 
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Chart 3.4. Averaged mode 
insert sizes (base pairs) at 
different DNA input 
concentrations (0.1, 0.2, 0.3 
ng). Optimization step 1. 
Data points (◊) represent 
average values of 3 
measurements. 
a) E. meningoseptica mode 
insert sizes versus 
concentration; 
 
 
 
 
 
 
b) P. aeruginosa mode 
insert sizes versus 
concentration; 
 
 
 
 
 
 
c) E. coli mode insert sizes 
versus concentration. 
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3.1.3. Nextera XT optimization Step 2 
To validate the results of Optimization step 1, second Optimization was carried out. At this 
stage optimum incubation time (5 minutes) and broader range of DNA input concentrations 
(0.1, 0.2, 0.3 and 0.4 ng/µl) were used with all three bacteria (Chart 3.5). This stage also 
aimed to prevent the possible problems associated with inaccurate pipetting, therefore small 
amounts of DNA (less than 5 µl) during the dilution step were avoided, as well as only 
electronic pipettes were used. As in the first stage sequencing results were analysed using 
Galaxy and visualised employing Qualimap. 
Sample ID Species Conditions 
1218-10 E. coli 01ng 
1218-11 E. coli 02ng 
1218-12 E. coli 03ng 
1218-13 E. coli 04ng 
901-10 P. aeruginosa 01ng 
901-11 P. aeruginosa 02ng 
901-12 P. aeruginosa 03ng 
901-13 P. aeruginosa 04ng 
501-10 E. meningoseptica 01ng 
501-11 E. meningoseptica 02ng 
501-12 E. meningoseptica 03ng 
501-13 E. meningoseptica 04ng 
Chart 3.5. Sample parameters of the Optimization step 2. 
 
The mode insert sizes (averaged) were calculated form insert size histograms. In E. 
meningoseptica samples (Chart 3.6, a) as well as in P. aeruginosa (b) no concentration-
specific trend is observed. The average mode values randomly fluctuate with the highest peak 
of 0.2 ng and 0.3 ng for E. meningoseptica and P. aeruginosa respectively. However, in E. 
coli samples (c) mode insert sizes show significant concentration-dependant trend, 
considerably increasing along with the concentration. Therefore, DNA input concentration of 
0.4 ng was used in subsequent Mate Pair experiments. 
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 a) 
 b) 
 c) 
Chart 3.6. Averaged mode insert sizes (base pairs) at different DNA input concentrations 
(0.1, 0.2, 0.3, 0.4 ng) of: a) E. meningoseptica, b) P. aeruginosa and c) E. coli. 
Optimization step 2. Data points (□) represent average values of 3 measurements. 
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3.1.4. Contig map (1) 
After Optimization steps using MIRA software reads were assembled into contigs. The 
sample with lowest amount of contigs was selected. The best result for E. meningoseptica was 
0.1ng, 5mins giving 50 contigs in total. Due to the complexity of the genome the best result 
for P. aeruginosa gave over 300 contigs, making manual process of contig map creation 
almost impossible. Therefore this step was performed only for E. meningoseptica (P. 
aeruginosa contig amount were further reduced in Mate Pair sequencing). To start the process 
of contig joining (as well as the process of genome finishing) each end of the contig (mostly 
containing multiple linkage options) was examined using Gap 5 software. To evaluate the 
coverage of each end the software used HAsh Frequency (HAF) tags, which display the status 
of read parts in comparison to the whole genome (Figure 3.4). The following HAF tags are 
applied to the fragments based on coverage: HAF2 – coverage below average, HAF3 – 
coverage is at average, HAF4 – coverage above average, HAF5 – probably repeat, HAF6 – 
‗heavy‘ repeat, HAF7 – ‗crazy‘ repeat. Consequently based on Gap 5 results the initial Contig 
map (Figure 3.5) was created indicating all possible connections between contigs. 
 
Figure 3.4. Gap 5 screenshot - part of the contig 1. Colours represent fragments tagged with different 
HAF tags. HAF3 – green, HAF4 – yellow, HAF5 – red. 
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Figure 3.5. Nextera XT result based contig map (Created in MS Office Word, using Gap 5 data). C – contig, rep – repeat, n/m – no matches found in Gap 5. 
Coloured lines represent connections between contigs, marked with HAF tags. HAF2 – light green, HAF3 – green, HAF4 – yellow, HAF5 – red.
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3.2. Mate pair sequencing 
To obtain more precise information about contigs as well as to join them into scaffolds 
Nextera Mate Pair sequencing was carried out. Mate Pair sample preparation technology 
allows the creation of libraries with long insert sizes ranging from 2 to 12 kb. Using Mate Pair 
sequencing in addition to conventional paired-end sequencing creates a very powerful strategy 
for many applications including genome finishing. 
Nextera Mate pair principle is similar to Nextera XT, however is more complex and has 
additional features that enhance sequencing results. It involves specific mate pair 
transposome, which tagment DNA, adding a biotin junction adapter. This adapter is later used 
to detect the location where the ends of fragments have joined to form a mate pair. DNA is 
then circularized in blunt ended intramolecular ligation. Circularized molecules are physically 
shared, and further biotin-selected. TruSeq indexing adapters are then added to the ends of 
mate pair fragments, and are used in following DNA amplification. 
 
3.2.1. Quality control (Bioanalyzer) 
Quality control of mate pair fragments was performed after AMPure Purification of Strand 
Displacement reaction and after PCR clean-up. After Purification of Strand Displacement 
reaction all samples (Figure 3.6, 1-4; Figure 3.7) showed same results – 2000 to 10 000 bp 
long, good purity and high concentration fragments. 
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Figure 3.6. Gel image (MP) of Elizabethkingia meningoseptica, E. coli, Pseudomonas aeruginosa 901 
and 950 after AMPure Purification of Strand Displacement reaction (sample 1-4) and after PCR clean-
up (sample 5-8). Numbers on the left show DNA insert sizes in base pairs (bp). L – DNA ladder. Two 
lines represent lower (   ) and upper (   ) markers. 
 
After PCR clean-up Bioanalyzer analysis showed that fragment sizes in different samples 
varied (ranging from 240 to 700 bp; Figure 3.6, 5-8; Figure 3.8). According to Mate pair 
protocol final size of libraries, obtained using Gel-free method, should be in a range between 
300 and 1500 bp. The molarity of the sample should be between 5 and 50 nM. Chart 3.7 
indicates that E. meningoseptica showed the best Mate pair sample preparation results with 
mode library size of 500 bp. Both P. aeruginosa 901 and P. aeruginosa 950, however, (most 
likely) experienced some sample loss, therefore library sizes were slightly lower than 
optimum value. Nevertheless, the molarity of all samples was optimal. 
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No Sample Peak size, bp Conc. [ng/μl] Molarity, [nmol/l] 
5 E. meningoseptica 503 6.44 19.4 
6 E. coli 385 5.22 20.6 
7 P. aeruginosa 901 278 2.58 14.1 
8 P. aeruginosa 950 240 3.71 23.4 
Chart 3.7. Bioanalyzer peak (mode insert size) data. Mate pairs PCR cleaned-up samples. Conc – 
Concentration.  
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1) 
 
2) 
 
3) 
 
4) 
Figure 3.7. Bioanalyzer summary electropherograms (MP1) of: 1) E. meningoseptica, 2) E. coli, 3) P. aeruginosa 901 and 4) P. aeruginosa 950 after AMPure 
Purification of Strand Displacement reaction. Electropherogram represents Fluorescence intensity (FU) versus Size (bp). Two sharp peaks are lower (35 bp) and 
upper (10380 bp) markers. 
 60 
J. Sostare, 2013 
 
5) 
 
6) 
 
7) 
 
8) 
Figure 3.8. Bioanalyzer summary electropherograms (MP2) of: 5) E. meningoseptica, 6) E. coli, 7) P. aeruginosa 901 and 8) P. aeruginosa 950 after PCR clean-up. 
Electropherogram represents Fluorescence intensity (FU) versus Size (bp). Two sharp peaks are lower (35 bp) and upper (10380 bp) markers.  
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3.2.2. Mate pair results 
The results of Mate pair sequencing were large amount of short paired-end fragments and 
wide range of long mate-paired fragments (Chart 3.8). Mate Pair sample preparation kit 
considerably enhanced sequencing results increasing the mode insert sizes from average 450 
bp to 1800 bp. The mode insert size (Chart 3.9 a) for E. meningoseptica, was approximately 
1600 bp, for E. coli – 1700 bp and for P. aeruginosa – 2100 (901) and 1900 bp (950). In 
Nextera XT 2
nd
 optimization step as well as in Mate Pairs insert sizes increased along with 
GC content. The average coverage (Chart 3.9 b) also considerably increased (5-7 times) 
compared to paired-end results. However, both paired-end and Mate Pair results indicated a 
similar trend – coverage was the highest in E. meningoseptica and lowest in P. aeruginosa 
(and E. coli in the middle). This trend was most likely observed due to the size of the 
genomes (P. aeruginosa has the largest genome and E. meningoseptica – smallest) or due to 
different GC content (highest in P. aeruginosa and lowest in E. meningoseptica), or both. 
Moreover, Mate Pair sequencing considerably simplified scaffolding and reduced finishing 
effort for E. meningoseptica genome. 
 a) 
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 b) 
 
c) d) e) 
 
f) g) h) 
Chart 3.8. Mate Pair insert size histograms. Histograms a (E. meningoseptica), c (P. aeruginosa 901), 
d (P. aeruginosa 950), and e (E. coli) represent overall Mate Pair results, where high peaks between 0 
and 500 bp represent paired-end fragments, lower peaks from 500 bp – mate pairs. Histograms b (E. 
meningoseptica), f (P. aeruginosa 901), g (P. aeruginosa 950), and h (E. coli) show filtered mate pair 
fragments across different insert sizes. 
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 a) 
 b) 
Chart 3.9. Mode insert sizes (base pairs; a) and average coverage (x – times; b) for E. 
meningoseptica, E. coli and P. aeruginosa (901 and 950) after Nextera XT first optimization step 
(blue), second optimization step (orange) and Mate Pair sequencing (green). 
 
3.2.3. Scaffolding 
During this step scaffolding was performed using SSPACE software, which joined 50 contigs 
of E. meningoseptica into 24 scaffolds (number of scaffolds for P. aeruginosa still remained 
high (over 200), requiring further optimization and computational processing). Main scaffolds 
No 1-10 and 13 (Chart 3.10) were non-repetitive sequences (excluding some repeats already 
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assembled in scaffolds), which together form the chromosome with the gaps in between. 
Repetitive fragments (No 11, 12, 14-24; Chart 3.11) subsequently should fill in the gaps 
between non-repetitive contigs, thereby making the whole genome. 
Scaffold Contigs in the 
scaffold 
Gap size, bp Scaffold Contigs in 
the scaffold 
Gap size, bp 
Scaffold 1 
c5 gaps-472 
Scaffold 5 
c17 gaps-1367 
c2 gaps-400 c24 gaps-458 
c12 gaps177 c29 gaps-632 
rep c265 gaps-1198 rep c256 gaps-320 
c21 gaps-376 c23 gaps-493 
c28 gaps-124 c26 gaps-546 
c4 gaps-693 c14 
 rep c250 gaps-899 
Scaffold 6 
c45 gaps-51 
c25 gaps-551 c1 gaps-813 
c20 gaps-719 c10 gaps87 
c7 
 
rep c251 gaps-298 
Scaffold 2 
c19 gaps-692 c16 gaps-206 
c27 gaps-592 c33 gaps164 
c11 
 
c18 
 Scaffold 3 c3 
 
Scaffold 7 c13 
 
Scaffold 4 
c8 gaps-481 Scaffold 8 c15 
 c22 
 
Scaffold 9 
c9 gaps-289 
   
c6 
 
   
Scaffold 10 c30 
 
   
Scaffold 13 c31 
 
Chart 3.10. Main scaffolds created with SSPACE. C – contig. 
 
 
 
 
 
 
 
 
Chart 3.11. Repetitive fragments. Scaffolds created with SSPACE. Rep – repeat. 
 
Repetitive fragments Contigs Repetitive fragments Contigs 
Scaffold 11 rep c252 Scaffold 19 rep c259 
Scaffold 12 rep c253 Scaffold 20 rep c258 
Scaffold 14 rep c254 Scaffold 21 rep c257 
Scaffold 15 rep c262 Scaffold 22 rep c260 
Scaffold 16 rep c263 Scaffold 23 rep c266 
Scaffold 17 rep c255 Scaffold 24 rep c261 
Scaffold 18 rep c264   
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Scaffolding process allowed facilitating the initial Contig map creating a Simplified map (No 
2; Figure 3.9). Most of contigs were now certainly connected to each other making scaffolds 
(leaving only a few contigs without scaffolded connections), what considerably reduced 
possible variations, however, the scaffold ends still had a number of probable connections. In 
the next steps it was attempted to join these scaffold ends together and fill in the gaps in 
between contigs. 
 
Figure 3.9. Simplified Contig map (No2). Green lines – scaffolded connections, red and yellow – 
possible connections (Gap5 determined), light green lines – no matches (N/M) determined. C – 
contig. 
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3.3. E. meningoseptica Genome finishing 
3.3.1. Direct PCR. Preliminary data. 
In order to finish the genome of Elizabethkingia meningoseptica 501 – fill in the gaps 
between scaffolded contigs generated during Mate pair sequencing as well as to estimate non-
scaffolded connections (and to join the scaffolds), direct PCR was performed. Reactions 
estimating the connection between 2 contigs (or validating the connection and filling in the 
gap if contigs are in the scaffold) were created based on the second (simplified) Contig Map. 
Firstly, PCR was carried out using the protocol suggested conditions (0.025 units/µl of Taq 
Polymerase, 58 ºC annealing temperature, and 1 minute extension time). During this stage 
only one connection was detected (Reaction No 27; Reaction list in Appendix III) employing 
Gel Electrophoresis. However, this reaction Electropherogram showed very weak band 
(Figure not shown), therefore PCR Optimization was carried out. 
 
3.3.2. PCR Optimization 
PCR Optimization was performed for the Reaction No 27 (Figure 3.10), varying the amount 
of Taq Polymerase (0.025 – 0.1 units/µl), lowering the annealing temperature (which was 
estimated to be too high for primers) from 50-56 ºC and changing the extension time to 3 
minutes (to give enough time for building required product). Sample number 5 (0.05 units of 
Taq, 52 ºC annealing temperature) showed the best result during Optimization step, therefore 
this conditions were used in subsequent PCR experiments. 
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Figure 3.10. PCR Optimization Gel image. Reaction No 27. L – DNA Ladder, 1-12 – samples. 
Sample conditions (First number – Polymerase in units/µl, Second number – annealing 
temperature in ºC): 1 – 0.025, 50; 2 – 0.05, 50; 3 – 0.1, 50; 4 – 0.025, 52; 5 – 0.05, 52; 6 – 0.1, 52; 7 
– 0.025, 54; 8 – 0.05, 54; 9 – 0.1, 54; 10 – 0.025, 56; 11 – 0.05, 56; 12 – 0.1, 56. Fragment sizes 
(according to ladder) represented in base pairs (bp). Agarose gel 1.5%, stained with Sybr Safe. 
 
3.3.3. PCR 
At this stage all PCR reactions were carried out using 0.05 units/µl of Taq Polymerase, 52 ºC 
annealing temperature and 3 minutes extension time. Almost all connections between contigs 
in scaffolds (Reaction No 1-5, 7-11, 13-17, 19-22 and 40; excluding reactions, where product 
was larger than ~ 6 kb – Taq Polymerase limit; for these reactions Long range polymerase 
was used) were validated after optimization (Figure 3.11). Moreover, new connections were 
discovered (Reaction No 24, 27, 28, 47, 56, 75, 80), linking scaffolds together. Furthermore, 
to obtain sequences of the products (to fill in the gaps and validate new connections) Sanger 
sequencing was performed. 
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Figure 3.11. PCR (optimized) Gel image. Reaction No 1-17. L – DNA Ladder, 1-17 – samples. 
Fragment sizes (according to ladder) represented in base pairs (bp). Agarose gel 1.5%, stained with 
Sybr Safe. 
 
3.3.4. Long-range PCR 
To obtain the products larger than 6 kb Long range (LR) PCR was carried out. Conditions 
used in LR PCR were protocol suggested – Taq LA Polymerase, 0.05 units/µl final 
concentration and thermocycling conditions mentioned in methods. However, the products 
failed to develop (even a positive control) as the conditions of LR PCR were unsuitable 
(therefore, LR PCR requires future optimization). 
 
3.3.5. Third Contig map 
After the PCR step scaffolded connections were validated and 7 new connections were 
obtained. That enabled the creation of the Third Contig map (Figure 3.12), and left only 4 
connections undetermined, giving 7 possible variants (determined employing Tablet). All 
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contigs were then joined into appropriate scaffolds (according to Chart 3.10) giving the final 
scaffold map (Figure 3.13). 
Figure 3.12. Third Contig map. Green lines – scaffolded connections, red – possible connections 
(Tablet determined), blue – PCR determined connections. C – contig. 
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Figure 3.13. Scaffold map. Blue figures represent scaffolds with free ends, grey – with joined ends. 
Lines – still possible connections (according to Tablet). Rep – repetitive contig. 
 
3.3.6. Sanger sequencing 
Sanger sequencing was the final stage of genome finishing. It was used to validate PCR 
products by determining their sequence and aligning the sequence using BLASTN (in Galaxy 
software) to scaffoldded sequences of E. meningoseptica. Successful Sanger sequencing 
results (clean from noise sequences) were obtained with almost all samples (5 reaction 
products were sequenced – No 17, 47, 56, 75, 80, each with 2 primers from either 3‘ (a) or 5‘ 
end (b) giving 10 samples (1 - 17a, 2 - 17b, 3 - 47a and so on) in total), excluding reaction No 
47 (a and b), where high frequency noise was detected. In all other samples the identity ratio 
with the estimated contigs was from 97-100%, what validated these connections between 
contigs. 
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3.4. Annotation 
3.4.1. Genome features 
To obtain genome annotations assembled bacterial sequences were analysed in RAST 
software. Genome size of Elizabethkingia meningoseptica was evaluated for the first time in 
this study and was estimated to be 4,173,270 bp. Genome sizes of Pseudomonas aeruginosa 
varied drastically (however, still were in predicted range) being 5,943,010 bp for specimen 
901 and 6,545,995 bp for 950. E. coli genome size was 5,407,699 bp. GC content was 
estimated to be 36, 66, 66 and 51% for E. meningoseptica, P. aeruginosa 901, P. aeruginosa 
950 and E. coli, respectively. Number of coding sequences for E. meningoseptica, P. 
aeruginosa 901, P. aeruginosa 950 and E. coli were 3858, 5444, 6066 and 5492; and number 
of RNAs 54, 64, 61 and 128, respectively. 
 
3.4.2. Subsystems 
RAST software divided all genomes into 27 subsystems (Chart 3.12-3.15), which were 
further allocated in 15 categories: Cofactors, Vitamins, Prosthetic Groups, Pigments; 
Membrane and membrane transport; Resistance; Metabolism; Mobile elements; Nucleosides 
and Nucleotides; Cell cycle; Regulation; Lipids; Respiration; Stress Response; Amino Acids 
and Derivatives; Carbohydrates; Motility and Chemotaxis; Miscellaneous. 
In all 4 bacteria analysed Metabolism was the largest category comprising 25-27% of the 
genome. Percentage ratio of two other large categories – Amino Acids and Derivatives and 
Carbohydrates was similar in Elizabethkingia meningoseptica (18% and 14%), Pseudomonas 
aeruginosa 901 (20% and 9%) and 950 (16% and 9%), however, E. coli showed completely 
opposite trend (9% and 18%). Cofactors, Vitamins, Prosthetic Groups, Pigments were 
represented by 6-9%. The most important category in pathogenic bacteria – Resistance 
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comprised 3-5% of the genome. Another groups also important in pathogens – Membrane and 
membrane transport, and Stress Response was represented by 8-11% and 3-5% respectively. 
Motility and Chemotaxis group was present in all bacteria, excluding E. meningoseptica as it 
is non-motile organism. Other categories were quite small – represented in all bacteria by 5% 
or less. 
 
Chart 3.12. E. meningoseptica subsystems. Each subsystem is represented with different colour and 
its percentage ratio to the whole genome is showed. N – total number of features in subsystems. 
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Chart 3.13. P. aeruginosa 901 subsystems. Each subsystem is represented with different colour and 
its percentage ratio to the whole genome is showed. N – total number of features in subsystems. 
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Chart 3.14. P. aeruginosa 950 subsystems. Each subsystem is represented with different colour and 
its percentage ratio to the whole genome is showed. N – total number of features in subsystems. 
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Chart 3.15. E. coli subsystems. Each subsystem is represented with different colour and its percentage 
ratio to the whole genome is showed. N – total number of features in subsystems. 
 
3.4.3. Resistance patterns 
To prevent or treat the infection associated with pathogenic bacteria it is crucial to know the 
patterns of Virulence, disease and defence system. In order to survive bacteria have developed 
various systems, which became even more intricate in multidrug resistant pathogens. All four 
studied strains showed specific Virulence, disease and defence system patterns (Chart 
3.16).  The system was comprised of 4 categories: bacteriocins, ribosomally synthesized 
antibacterial peptides; resistance to antibiotics and toxic compounds; invasion and 
intracellular resistance; and adhesion (represented only in E. coli). 
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Bacteriocins and ribosomally synthesized antibacterial peptides (possessing tolerance to 
colicin E2) were represented in all bacteria, excluding E. meningoseptica. The largest and the 
most significant category – resistance to antibiotics and toxic compounds varied dramatically. 
The group, which represented cobalt-zinc-cadmium resistance, was the largest in all system 
varying from 13 (E. coli) – 39% (E. meningoseptica). Second biggest system‘s group (in P. 
aeruginosa 901, however, second biggest is copper homeostasis) – multidrug resistance efflux 
pumps, which are important as export different compounds (including antibiotics) from the 
cell were almost equally represented in all strains (11-13%). Other 5 groups, which were 
common for all 4 organisms comprised 3-19% of the system. All organisms were tolerant to 
copper, resistant to fluoroquinolones, arsenic and β-lactams, and possessed tripartite 
multidrug resistance systems. Opr efflux systems were specific for P. aeruginosa specimens 
and all strains, excluding E. meningoseptica had Multiple Antibiotic Resistance (MAR) locus, 
which play a role in efflux system regulation.  Additionally, E. meningoseptica and P. 
aeruginosa 950 were resistant to vancomycin, but P. aeruginosa 950 and E. coli to mercury. 
Moreover, E. meningoseptica was resistant to chromium compounds, P. aeruginosa 950 to 
fosfomycin. 
Furthermore, invasion and intracellular resistance category was comprised of virulence 
operons (involved in SSU and LSU protein synthesis, DNA transcription, quinolinate 
biosynthesis, lipid metabolism), which were fully represented in E. meningoseptica, and 
represented with some exceptions in P. aeruginosa 901, 950 and E. coli. 
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a)     b) 
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c) d) 
Chart 3.16. Virulence, disease and defence subsystem‘s features in: a) E. meningoseptica, b) P. aeruginosa 901, c) P. aeruginosa 950 and d) E. coli. N – total 
number of features in subsystem. 
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3.4.3.1. E. meningoseptica resistance 
The resistance of E. meningoseptica was studied in details and species with the most similar 
resistance patterns were identified. According to the Chart 3.17 resistance patterns of E. 
meningoseptica most closely resemble Flavobacterium johnsonia johnsoniae UW101 
patterns, sharing over 50% of chromosomal regions. Resistance of E. meningoseptica is also 
similar to Chitinophaga pinensis DSM 2588 and Spirosoma linguale DSM 74 resistance, 
sharing 36 and 26 % of chromosomal regions, respectively. Other species share less than 25% 
of resistance regions with E. meningoseptica. Interestingly, detailed analysis of E. 
meningoseptica resistance showed that bacterium shares several genes (4; example - Chart 
3.18.) with Anopheles gambiae (African malaria mosquito). 
No Species sharing similar resistance chromosomal regions Amount 
1 Flavobacterium johnsonia johnsoniae UW101 56 
2 Chitinophaga pinensis DSM 2588 36 
3 Spirosoma linguale DSM 74 26 
4 Pedobacter heparinus DSM 2366 21 
5 Dyadobacter fermentans DSM 18053 19 
6 Flavobacterium psychrophilum JIP02/86 18 
7 Cytophaga hutchinsonii ATCC 33406 12 
8 Croceibacter atlanticus HTCC2559 12 
9 Gramella forsetii KT0803 8 
10 Robiginitalea biformata HTCC2501 6 
Chart 3.17. Species sharing similar patterns of resistance with E. meningoseptica.  Numbers (right) 
represent the amount of chromosomal regions which are similar to E. meningoseptica (out of 100). 
 
Resistance gene 
product 
Organisms with similar chromosomal region  Contig No 
Multicopper oxidase 
Anopheles gambiae (African malaria mosquito) 
Contig 10 
Anopheles gambiae str. PEST 
Flavobacterium johnsonia johnsoniae UW101 
Chitinophaga pinensis DSM 2588 
Chart 3.18. E. meningoseptica gene product (multicopper oxidase) comparison to other similar 
species (created by RAST). 
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3.4.4. Phylogenetics 
Furthermore, relatedness of studied strains to other bacteria was analysed building 
phylogenetic trees in snpTree1.1 software (excluding E. meningoseptica). Due to the fact that 
no complete genomes of Elizabethkingia genus are available, E. meningoseptica trees were 
built using 16S Small Subunit Ribosomal RNA and DNA-directed RNA polymerase beta 
subunit (EC 2.7.7.6) in BLASTN software (Figure 3.14). According to 16S subunit tree the 
most closely related strain to E. meningoseptica 501 is E. meningoseptica R3-4A. DNA-
directed RNA polymerase based tree showed complete bacterial genomes that are most 
closely related to 501 strain. From those Riemerella anatipestifer DSM 15868 and RA-GD 
strains appeared to be the closest relatives of E. meningoseptica 501 (also according to 
RAST). 
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Figure 3.14. E. meningoseptica phylogenetic trees (strain 501 is highlighted). 16S Small Subunit 
Ribosomal RNA (top) and DNA-directed RNA polymerase beta subunit (bottom) based trees. 
Number at the bottom shows the evolutionary distance between strains. 
 
P. aeruginosa phylogenetic tree (Figure 3.15) shows the relatedness of 901 and 950 
specimens to all other P. aeruginosa strains (also showed in Appendix IV) with complete 
genomes (available from snpTree1.1). P. aeruginosa 901 and 950 are closely related as 
expected. Specimen 950 also is closely related to LESB58 strain. However, RAST software 
(using different approach – comparing the amount of same genes present in other species) 
showed that both specimens are most closely related to 19BR strain (not present in 
snpTree1.1 system) and NCGM2_S1 strain. 
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Nevertheless, E. coli phylogenetic tree (Figure 3.16) shows that from a variety of genomes 
available O104:H4_1218_280 strain is most closely related to strain 55989 (also Appendix IV). 
 
Figure 3.15. P. aeruginosa phylogenetic tree. Studied specimens (901 and 950) are coloured. Number 
at the bottom shows the evolutionary distance between strains. 
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Figure 3.16. E. coli phylogenetic tree. Studied strain (O104:H4_1218_280) is coloured in green. Number at the bottom shows the evolutionary distance between 
strains. 
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4. Discussion 
 
4.1. Paired-end whole-genome sequencing (Nextera XT) 
The development of widely available and inexpensive high-throughput DNA sequencing has 
opened new horizons in life sciences, allowing the sequencing of large genomes in a matter of 
days. In microbiology HTS enabled discovering completely new approaches in many 
disciplines including gene expression analysis, mutation mapping, analysis of noncoding 
RNAs, metagenomics and whole-genome analysis (Lu et al., 2005; Malde, 2008; Mardis, 
2008; Pop & Salzberg, 2008). 
The accurate and successful preparation of DNA libraries for next-generation sequencing is a 
crucial step, which can be very challenging, and particularly for isolates with low DNA yield. 
Nextera XT Illumina sample preparation kit offers a solution for this problem as requires only 
1 ng of input DNA. Nextera technology was designed in 2009 by Epicentre Biotechnologies 
(Caruccio et al., 2009), further purchased by Illumina Inc. in 2010. Nextera XT is one the 
most recent Nextera kits launched by Illumina in 2012. Due to the fact that technology is 
completely new only a few papers has been published employing Nextera paired-end strategy. 
Recently, Marine et al. (2011) evaluated Nextera protocol suitability for microorganisms 
using six phage genomes. The study indicates that the preciseness of Nextera sequencing was 
more than 99%, when comparing sequences obtained with Nextera and complete genome 
sequences available. Moreover, De novo genome assemblies, obtained in the same study, 
provided long contigs. These two factors make Nextera protocol a really good method for de 
novo assembling. 
So far no study attempted to optimize Nextera XT protocol, therefore this study findings are 
novel. Optimization of sample preparation conditions showed that incubation time has no 
effect on the results, on contrary, DNA input concentration influences fragment length, but 
 85 
J. Sostare, 2013 
only in E. coli samples. Nevertheless, this impact may increase in future experiments, if 
broader ranges of concentrations are used. 
According to Marine et al. (2011), library fragments (mean) were 300 – 800 bp long, what is a 
good result. However, authors noticed that the mode value was higher in samples with higher 
DNA concentration, assuming that this is an effect of fragment ‗nesting‘ – a phenomenon, 
when during limited-cycle PCR, along with the concentration increase, fragments create non-
covalent bounds between the adaptors  (it forms a false gel line – narrow and very 
concentrated – in Bioanalyzer results). Nevertheless, in current study no such an effect was 
observed. Marine et al. also indicated that GC content may affect the coverage of sequences, 
as during PCR step GC-rich and GC-poor sequences may be underrepresented (Aird et al., 
2010; Kozarewa et al., 2009). Nevertheless, using the appropriate coverage Nextera is able to 
generate a high-quality data for many applications (Marine et al., 2011). In current study, 
however, no correlation between GC and fragment insert sizes was determined. The mean 
insert size values were similar for all species being 477, 526 and 521 base pairs for 
Pseudomonas aeruginosa 901 (high GC), Escherichia coli (medium GC) and Elizabethkingia 
meningoseptica (low GC) respectively. 
 
4.2. Mate Pair sequencing 
Mate Pair technology, as well as conventional paired-end method, apart from sequence data 
provides information about the distance between two reads. This information is valuable in 
structure rearrangement (e.g. insertions, deletions) determination and in assembling of 
repetitive regions. However, unlike paired-end data, Mate Pair data can provide user with 
information about the regions separated by large distances (2-20 kb; Nieuwerburgh et al., 
2011). Mate pair technique generates 3 types of fragments: long range or mate pairs, short 
range or paired-ends and junction pairs, containing 1 chimeric read (only 1 end of the initial 
fragment instead of 2; Walenz et al., 2011). Obtaining the high amount of desirable high-
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quality mate pair fragments is very challenging, as in many cases libraries are overrepresented 
by large quantities of paired-ends and junction pair fragments. 
Nextera Mate Pair sample preparation kit was introduced by Illumina only half a year ago 
(January 2013), therefore no studies have evaluated the sample preparation efficiency yet. 
This new, improved (the first Illumina Mate Pair Library Prep V2 kit was introduced in 2009) 
Mate Pair kit has several important features: it is the only kit with gel-free method, which 
generates Mate Pair libraries up to 12 kb; gel-free method is very efficient, when DNA 
amounts are limited; preparation requires only 2 days (Illumina, 2013). 
Until now only several studies employed Illumina Mate Pair technology to sequence, for 
instance, the genome of yeast (Saccharomyces cerevisiae; Nieuwerburgh et al., 2011) and 
human cancer cell lines (Arlt et al., 2011; Murphy et al., 2012). However, no study attempted 
to use it in microbiology. Nieuwerburgh et al. (2011) indicated the main disadvantages of 
Mate Pair (Library Prep V2, Illumina) protocol. First, authors note, that biotin enrichment 
step is not ideal, therefore longer sequencing reads result in probability of crossing the 
junction adapter (the longer read length the higher probability). Moreover, the junction 
adapter has no recognizable sequences, leading to difficulties in identifying reads that passed 
through the junction, and complicating mapping process. Consequently Library Prep V2 
protocol suggests limiting the read length to only 36 bases (Nieuwerburgh et al., 2011). 
Nextera Mate Pair protocol offers a solution as contains identifiable junction adapter 
sequences, moreover, to minimize adapter bias problems Illumina provided a technical note 
(Illumina, 2012b) for computationally analysing and processing chimeric reads. Second 
problem with Library Prep V2 protocol is the large amount (18) of PCR cycles 
(Nieuwerburgh et al., 2011). PCR often produces duplicate sequences and amplification bias, 
what decreases density of libraries, therefore it is essential to minimize cycle amount when 
possible (Kozarewa et al., 2009). This problem was also eliminated with creation of Nextera 
Mate Pair protocol, drastically reducing PCR cycle number to only 10 (in gel-free protocol). 
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Present study indicates that even without optimization Nextera Mate Pair protocol allows 
generating a high-quality data, which undoubtedly facilitate genome finishing effort. 
Moreover, mate pair fragments are of a good length, and fragment distribution is very similar 
across all species, even despite that P. aeruginosa fragment yield is lower (however its 
genome is very complex as well). These facts indicate that protocol is robust and reliable. 
Nevertheless, it is reasonable to apply Mate Pair gel-plus protocol in future experiments, what 
most likely will give even better results. 
Additionally, when preparing Mate Pair libraries it is also important to note GC content of an 
organism. In current study coverage (both in Nextera XT and Mate Pairs) increased when GC 
content decreased, however it presumably was due to the decreasing size of bacterial genomes 
(largest genome as well as GC in P. aeruginosa, and smallest genome and GC in E. 
meningoseptica). Therefore, most likely, there is no link between coverage and GC, though it 
requires further investigation. 
Furthermore, library insert size (main) obtained in study by Nieuwerburgh et al. (2011; the 
authors used modified protocol with their-invented Cre-Lox recombination to improve Mate 
Pair performance) were around 3 kb, with the mode value ~ 2200 base pairs. In other studies 
by Arlt et al. (2011) and Murphy et al. (2012) similar results were obtained (main insert size ~ 
3 kb). All studies, however, used Mate Pair Library Prep V2 protocol. Despite that no study 
tested the Nextera Mate Pair protocol yet, in the technical note (Illumina, 2012b) Illumina 
provided a model example of E. coli de novo genome assembly. The results indicated that 
median insert size was approximately 3 kb (mean not shown) and the mode ~ 2200 base pairs. 
Similarly, in current study mode insert sizes in all bacteria were close to 2000 bp, and the 
amount of high-quality mate pair fragments was promising, suggesting that the new protocol 
is working well. 
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4.3. E. meningoseptica genome finishing 
The final step of whole-genome sequencing project, when sequences are already assembled 
into scaffolds, involves gap closure (captured gaps) and scaffold end joining (uncaptured 
gaps). The gaps are formed due to regions that are missing from contigs – unclonable 
sequences, GC-reach and GC-poor regions or due to large repeats (Tettelin et al., 1999). 
Before the development of Next-generation sequencing finishing process was laborious and 
time consuming, and to span numerous gaps additional steps were required. For instance, it 
was possible to construct a shotgun clone library employing plasmid vectors and then perform 
additional double-strand sequencing with universal forward and reverse primers. This 
approach generated sequence data from both ends of most clones (but not all), and was 
followed by primer walking either on shotgun clone template (Fleischmann et al., 1995) or 
genomic DNA (Heiner et al., 1998). The method became more laborious, when the gap was 
larger than few hundred bp, moreover, the obtained connections required confirmation by 
PCR. Furthermore, the presence of repetitive regions made the process even more 
complicated as the average sequence read (of Sanger sequencer) was smaller than most of 
repeats, and the primer located outside could not get across the repeat. Therefore, one more 
additional PCR step was required to generate product across the gap, and perform primer 
walking directly on PCR product. However, this process required to test each contig end 
against all of the other ends, resulting in hundreds or thousands different combinations and 
PCR reactions (multiplex PCR (Burgart et al., 1992) and combinatorial PCR facilitated this 
step; Tettelin et al., 1999). 
Nowadays, HTS technology significantly simplifies scaffolding (especially after Mate Pair 
sequencing) and finishing effort making the number of possible connection variants minimal. 
To close the gaps in-between contigs, which are joined into scaffolds (captured gaps), is very 
easy as the connection between 2 contigs as well as direction of the contigs (flipped or non-
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flipped) are already known. Scaffold end joining (uncaptured gaps) is more complex as few 
combinations are still possible (which are determined by such programs as Gap5 and Tablet), 
however, due to the development of HTS technology testing each contig end against all of the 
other ends is unnecessary. Finishing step after high-throughput sequencing requires only 2 
steps – PCR with the unique primers, which are close to the end of the contig and PCR 
product sequence determination. 
If the amount of uncaptured gaps is still high, various PCR approaches can be used instead, 
including multiplex PCR (Chamberlain et al., 1988), inverse PCR (Triglia et al., 1988), 
restriction site PCR (Sarkar et al., 1993), capture PCR (Lagerstrom et al., 1991) and anchored 
PCR method (Mizobuchi & Frohman, 1993; Siebert et al., 1995; Rogers et al., 2005).  
When the number of uncaptured gaps is low they can be closed relatively fast by the direct 
PCR with every possible pair-wise combination of primers. After PCR product is obtained 
Sanger sequencing is performed to determine the gap sequence. This technology was 
successfully used in current study, and in a very short time period (~ 2 month) from initial 50 
contigs of E. meningoseptica genome 4 scaffolds were finally obtained. However, some 
contig connections cannot be determined using the original Taq polymerase as contain large 
repeats (6 or more kb) in-between contigs, therefore these few products should be obtained 
using Long Range PCR. Therefore, in order to complete E. meningoseptica genome some 
additional experiments (similar and not time-consuming) are still required. Furthermore, it is 
important to note that the progress in sequencing technology already greatly facilitated the 
genome finishing process, and further development of paired-end sequencing will most likely 
diminish the role of PCR in finishing process even more (Nagarajan, 2010). 
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4.4. Genome annotation 
So far no study addressed genome features of any Elizabethkingia genus members. In this 
study general features of E. meningoseptica genome were described and the approximate 
genome size was estimated for the first time. Being ~ 4.2 Mb long it is smaller than genomes 
of P. aeruginosa or E. coli, however still large genome for bacteria. The genome of E. 
meningoseptica close neighbour Riemerella anatipestifer DSM 15868, for example, is twice 
smaller (2.2 Mb; Yuan et al., 2011). E. meningoseptica resistance patterns also seem less 
complex and diversified than patterns of 2 other bacteria studied, especially due to the fact 
that this bacterium has no plasmid. Still quite large part of its genome (5%) is responsible for 
resistance. Additionally, interesting fact that bacterium shares several genes with Anopheles 
gambiae, may be explained by the inclusion of Elizabethkingia anopheles DNA fragments 
(which are highly similar to E. meningoseptica) into the genome of A. gambiae. Nevertheless, 
further analysis of E. meningoseptica genome is required to obtain a complete resistance 
picture. 
Obtaining a complete genome of P. aeruginosa is a great challenge due to the complexity and 
size of its genome. There are more than 10 P. aeruginosa genomes finished so far and 9 of 
them are available as a single chromosome from NCBI website database. As indicated by 
RAST system, specimen 950 genome and resistance patterns are more complex than 901, 
what is most likely due to the fact that 901 was sampled in water and 950 persisted in human. 
Strain 19BR is the closest relative of both specimen 901 and 950. This strain is multidrug 
resistant, and apart from usual fluoroquinolones, β-lactams resistance caries specific 
resistance to polymyxin B (widely used drug against Gram-negative bacteria; Boyle et al., 
2012). Second closely related strain NCGM_S1 induced urinary tract infection outbreak in 
Japan and were extremely resistant to aminoglycosides and β-lactams (Miyoshi-Akiyama et 
al., 2011). Another related strain – LESB58, (originated from Liverpool) that cause cystic 
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fibrosis in children, is specifically known for its ceftazidime resistance (Winstanley et al., 
2009). Furthermore, future experiments are required to complete the genome of P. aeruginosa 
ST395 and compare in details its genomic features to other genomes. 
Escherichia coli O104:H4 strain was extensively studied during 2011 outbreak of hemolytic 
uremic syndrome in Germany, thereby it is well-characterized. Complete genome sequence of 
German isolate is already published and the genome is annotated (Ahmed et al., 2012). 
Genome size, number of plasmids (3) and GC content of German isolate is very similar to 
isolate 1218_280 sequenced in current study. O104:H4 strain belongs to 
enteroaggregative type and is characterized by Shiga toxin 2 production and tellurite 
resistance. Both Shiga toxin 2 and tellurite resistance cluster are also present in O104:H4 
1218_280 specimen. Additionally, strain 55989 was determined to be the closest O104:H4 
relative (Rohde et al., 2011), what is in agreement with current study. 
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5. Conclusions 
 
The whole-genome sequencing (paired-end and mate paired) of three different bacteria - E. 
meningoseptica, P. aeruginosa and E. coli, was performed in this study. Nextera XT protocol 
optimization step one showed no significant concentration or time-dependant trend, however 
yielded fragments over 450 bp (mean) for all three bacteria, which suggest of a high 
efficiency of the protocol. During the second Nextera XT optimization step significant 
concentration-dependant trend was observed in E. coli samples (other bacteria showed no 
trend), therefore it was concluded that concentration of 0.4 ng will be most suitable in further 
sequencing steps. Paired-end sequencing also allowed joining sequences into contigs and 
created high-quality draft genomes of bacteria. Nextera Mate Pair sequencing considerably 
improved the results – the insert sizes as well as coverage were much greater than in paired-
end sequencing. Mate Pair information also allowed joining contigs into scaffolds and 
estimated the gaps and direction of contigs within scaffolds, what considerably simplified 
finishing effort. For the last step of genome finishing (only for E. meningoseptica), PCR was 
successfully optimized, and given above conditions are considered to be more efficient for 
finishing than manufacturer‘s protocol. However, Long Range PCR protocol still requires 
optimization. PCR step enabled joining scaffolds of E. meningoseptica into 4 (gaped) 
fragments only after several months of continuous experiments, what demonstrates an 
enormous progress of high-throughput sequencing during the last decade. Furthermore, 
genome features, such as genome size, subsystem distribution and patterns, resistance 
patterns, phylogenetics were discussed in the study. The genome of E. meningoseptica was 
described for the first time and it is the smallest and most likely the simplest genome amongst 
bacteria featured in current study. However, the resistance patterns of E. meningoseptica are 
still complex and resistance subsystem is a considerable part of its genome. Resistance 
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patterns of P. aeruginosa 950 and E. coli are the most diversified amongst studied bacteria, 
containing a wide range of resistance systems. Nevertheless, phylogenetic analysis showed 
that Riemerella anatipestifer appears to be closest E. meningoseptica neighbour. Both P. 
aeruginosa specimens appear to be close neighbours of 19BR strain, and E. coli is closely 
related to 55989 strain. In summary, modern technology already greatly facilitated finishing 
of small bacterial genomes and with further development HTS technology may be 
successfully used in many different applications. 
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Appendix I 
 
Contig No 5'FORWARD primer 3'REVERSE primer 5'REVERSE primer 3'FORWARD primer 
EM_S22_c1 TGCAATAGCTGTACGCATCA ACTCCCCGCACAATACAGTC GGCAGAAACCTTCTCTAGCAA CCAACATGGCTTACGGAAAA 
EM_S22_c2 GGTTAAAACGCAGGTTGAGG CGTTTTGCCATCTTAGTGAACTT CCCGGCCATATTGAAAAGAT CGGCTACCCGGTAATTGTAA 
EM_S22_c3 CCCTCCAAGATCTGCAACAT AACGCCGTGCTTAGAGGTTA CAGGCTTTGGAATAGCAACC AAAACCCTTTTGCCGGATT 
EM_S22_c4 TTTATCACGTGGAGCAGCAG AGCTCTAATCCGTGAGAATCG TTCATATACTCCGAATTTCTGGAAC TTTTGAGGATAACCATAAACAAGTAA 
EM_S22_c5 GCAGACTTGCCTCCTGTTCT CCGTGTCTTTATTGCTCTTGC AGGCACTTCCGTTATCGTTG GGTAATTTTCCAGCTTTACTTTTATCA 
EM_S22_c6 ACCAAGTGAAAATGGAAGCTTTA TGGGGAAATTCCAAAACAAA AAACAAATTAAAGCCCCAAAAA TGATATCGACAGAATGCAGGA 
EM_S22_c7            GAATTCCGAGCACCGATAAA AGACCCGGATACAGGACCTT GTGCTCGGAATTCAGGATGT ACATGGATCATTTCCGGTTT 
EM_S22_c8            AGGTTGCTCACCTGCCATAA AGTAGGTCAGCAGCCTTTCG CCGTAGATAATTCTGGCGAAA GGAAATCCGAGGCTCTCATA 
EM_S22_c9            GGGAAACCGTAATGCTGTGT CAGCGCTTATTGTTGCAGAA GCAAAAGCCTGAAGTCGTAGA TTTCCTCTGTACTCAGGCTTTACA 
EM_S22_c10           GATTGGTGACGCCAAAACTT AAGAAAACCGCGTATCATGG AAGTTTTGGCGTCACCAATC TGGTGTTTATATGCTGTGCATT 
EM_S22_c11           AGAACTCCCGCTACAACAGC GACCGATAAACCTTACGAGCTT CTCCGTTTCTGGTATTGTTGG TGGTTTGAAGCCGGAGTTAC 
EM_S22_c12           TCCACGCAGGATATCCATTT GATGGGGTACGAGGCTATCA TACGCTATTTTTCCGGCATT TGATAGCCTCGTACCCCATC 
EM_S22_c13           TGGTGGTTTGGTGTAACGAG GGAAATACTAAATGAACCGGAGTTT TGCTATAGGGACCTCACTTGC GAAAGATTGACCCGGGTTGT 
EM_S22_c14           GATCGTTTCCAGCCAAACTC CGGAAAAGTTTCGGATACCA TTTACCTCATAGCTGGATTTCAA TTGATTTTGGATAAATCTGTGTTGA 
EM_S22_c15           ATTGTCGCTCCGGAATAAGA TTGGAAGCAATAGCCTTCTTT GCTGACACCAAGTTGCAAAA TCCCGTTTTCAAAGTATCTGC 
EM_S22_c16           GTGCTTCTGGAGGAGCAGAG TTGCTTTCTTACGATAGAGTCAACA TCGAGTTGTATCCCTGATGTTTT AATGATGAAAACCGTTTCTTACAA 
EM_S22_c17           GATTGCATACCCAGGAGGTG CCTCCGGCTTCTAAAACACTC AGTGGGCATCAGCATCTTTT CCTTTATTCCTGCCGAAGGT 
EM_S22_c18           TCAACAAATTGCAAGAAAGCA TGTTTGCCTGATTTAAAATGACT TCAGCTTTTTCAAAATTAGGAGGT TGCATAACTCATTACCGATGCT 
EM_S22_c19           TTTGTCATTGCTGCAAGTCC TACCGACTTCGGAGGGGTAT CATCTTCACGGAACTGAGCA ATTCTTGCCCCGTAATCGTA 
EM_S22_c20           CCGACGGAAATGGTCTTACT TTCTCCGCTTTGAAAACGTC GGCCATTAATTCTGAGAGATGG GCATGGGCTCTTATGGCTAA 
EM_S22_c21           TGTCAGGCAAGGATTTAAAATTG TTTACGGAGCAAGAGCCATT GGGAACAGGGTTTGGTCTTT TCTTTTTGCAACTTTGGCATC 
EM_S22_c22 TCGGAATATTTTTGGGTGGA AAGTTGAACGGCGTTACTGC ACTAAGCAATGCGCTCCAGT GCTGAGATTGATGCAGCTTG 
EM_S22_c23           TACTGCACAGCCAGGACAAC CCTTAGGTAAAGCCCGGAAA CCATACCAATCGTGTGCATT TTCTTTGTCTGCGCTTTTCA 
EM_S22_c24           AGTGCTGCAGGAAGCATTTT CTTTGCTTCCCCTCTCTGC TGGGACAAAATACCAGCTCTC GGGAACTATATCGGCACAGG 
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EM_S22_c25           TGGAAAGACTCCCCCTCTTT AAATGCACATTCGCATAATGA GCGTAAAGCCGGATTTTTCT TCGAGGTAAAGGCTTTCCAA 
EM_S22_c26           ATCCCCCACCAGTCTACCTC CTCCAATCCAAGACCTTTGC GCTTGGGATAATTGCAGCAC GGGATGCTGAAGCTTGGTTA 
EM_S22_c27           TTGCTAATCTGATGGTTGAATGTT GCCAATAAAGAACGGGAGAA CCGTCTTTACTTTTCAACATTGG CACAATATGACCTTTCAGTACAAAGC 
EM_S22_c28           TTCCTGGGTCATGATTTGGT CGAATGTACCAGCTGTAACAAAG GCCGGAACTAAGGTCAACAA ATGGTTATCCGCCAGAATTG 
EM_S22_c29           TCACTCCAACCTCCCAAAAC TGCGTAATACACACTGGCTGT ACGTCTCCGTTTCGGAATTT GCGGGTTTTATTTTTGCTTTT 
EM_S22_c30           AGCTTTTACGGGGGACAGTT TGGACAGAAAGCAGCACGTA CAACAGGGCCAACACCTTTA CTGGTATCAGCTCCCAGGTT 
EM_S22_c31           GAAGCTCCGGAAGAGTCTGA AACTGAATACACGCGAGAAAAA TCCAGAGGAATACTTACTTTCTGACA GCCATTTTTATGATTTATAGGATGA 
EM_S22_c33           CAGAAAAATTCCCTTTGGTCTT CCTCCAAAAATTGACATGTTTC TTGGAGCTGCAACAACTACG TTCACCAGAATTATCTACTGCATTG 
EM_S22_c45     GCCGACGGTGTATGGTAAAT TGCAGCCACAATGCTTTATC GCATCCAATCGGAAAACATA AAATTGATAAAGCCCTCATTTG 
Chart A.1.  Primer sequences designed for Elizabethkingia meningoseptica 501 genome finishing. Unique primers of four different directions (3‘ and 5‘, forward 
and reverse) were designed for each contig (at least 500 bp from the end of the contig) employing Primer3 (v. 0.4.0) software.  
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Appendix II. 
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7) 8) 
9) 
Chart A.2.1. Insert 
size histograms of P. 
aeruginosa. Bars 
represent number of 
reads at different insert 
sizes, bp. 1-9 show 
different sample 
preparation conditions 
(listed in Chart 3.1, 
column 2). Created 
using Qualimap v0.7.1. 
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9) 
Chart A.2.2. Insert 
size histograms of E. 
coli. Bars represent 
number of reads at 
different insert sizes, 
bp. 1-9 show different 
sample preparation 
conditions (listed in 
Chart 3.1, column 1). 
Created using 
Qualimap v0.7.1. 
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Appendix III. 
Reactions Primer   Primer   Reactions Primer   Primer   
Reaction 
No 3'F Repeat 5'R Product size 
Reaction 
No 3'F Repeat 5'R Product size 
1 C5   C2 1,5 kb 19 C10 repC251 C16 2,75 kb 
2 C2   C12 1,25 kb 20 C16   C33 1 kb 
3 C12 
rep 
C265 C21 
2,25 kb 
21 C33   C18 1,5 kb 
4 C21   C28 1,75 kb 22 C9   C6 1,75 kb 
5 C28   C4 1,5 kb 23 C7   C3   
6 C4 repC250 C25 - 24 C7   C30 900 bp 
7 C25   C20 1,25 kb 25 C11   C17 - 
8 C20   C7 2 kb 26 C11   C31 - 
9 C19   C27 1,75 kb 27 C30   C3 700 bp 
10 C27   C11 1,25 kb 28 C14   C15 2,5 kb 
11 C8   C22 1,25 kb 29 C15   C13 - 
12 C17   C24 - 30 C18   C17 - 
13 C24   C29 1,25 kb 31 C15   C17 - 
14 C29 repC256 C23 1,5 kb 32 C6   C17 - 
15 C23   C26 1,25 kb 33 C31   C17 - 
16 C26   C14 1,25 kb 34 C18   C31 - 
17 C45   C1 550 b 35 C15   C31 - 
18 C1   C10 - 36 C6   C31 - 
Chart A.3.1. PCR reactions between different contigs, initial set. Created, based on Contig map No 1 and 2. Green colour indicates scaffolded connections, blue – 
PCR-determined connections, red – possible connections (probably containing large repeat, therefore product failed to develop), grey – excluded connections. 
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Reactions Primer   Primer 
 
Reactions Primer   Primer 
 Reaction 
No 3' Repeat 5' 
Product 
size 
Reaction 
No 3' Repeat 5' 
Product 
size 
37 C4_3'F   C25_5'F - 38 C4_3'R   C25_5'R - 
39 C17_3'F   C24_5'F - 40 C17_3'R   C24_5R 1,25 kb 
41 1_3'R   C10_5'R - 42 1_3'F   C10_5F - 
43 11_3'F   C17_5'F - 44 11_3'R   C17_5R - 
45 11_3'R   C31_5'R - 46 11_3'F   C31_5F - 
47 15_3'F   C13_5'F 550 bp 48 15_3'R   C13_5'R - 
49 15_3'F   C17_5'F - 50 15_3'R   C17_5'R - 
51 18_3'F   C17_5'F - 52 18_3'R   C17_5'R - 
53 6_3'F   C17_5'F - 54 6_3'R   C17_5'R - 
55 31_3'F   C17_5'F - 56 31_3'R   C17_5'R 500 bp 
57 18_3'F   C31_5'F - 58 18_3'R   C31_5'R - 
59 15_3'F   C31_5'F - 60 15_3'R   C31_5'R - 
61 6_3'F   C31_5'F - 62 6_3'R   C31_5'R - 
Chart A.3.2. PCR reactions between different contigs, set 2. Created, based on Contig map No 2. Green colour indicates scaffolded connections, blue – PCR-
determined connections, red – possible connections and grey – excluded connections. 
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Reactions Primer   Primer 
 
Reactions Primer   Primer 
 
Reactions Primer   Primer 
 Reaction 
No 3'F Repeat 5'R 
Product 
size 
Reaction 
No 3'F Repeat 5'F Product 
Reaction 
No 3'R Repeat 5'R 
Product 
size 
63 C22   C19   64 C22   C19   65 C22   C19 
 66 C3   C9   67 C3   C9   68 C3   C9   
69 C3   C45 - 70 C3   C45 - 71 C3   C45 - 
72 C6   C19   73 C6   C19   74 C6   C19   
75 C13   C19 3 kb 76 C13   C19   77 C13   C19   
78 C11 repC250 C9   79 C11 repC250 C9   80 C11 repC250 C9 400 bp 
81 C5_5' repC254 C8_5'   82 C5_5' repC254 C8_5'   83 C5_5' repC254 C8_5'   
84 C22_3'   C3_3'   85 C22_3'   C3_3'   86 C22_3'   C3_3'   
87 C22_3'   C13_3'   88 C22_3'   C13_3'   89 C22_3'   C13_3' 
 90 C11_3' repC250 C6_3'   91 C11_3' repC250 C6_3'   92 C11_3' repC250 C6_3' 
 
Chart A.3.3. PCR reactions between different contigs, set 3. Created, based on Contig map No 2. Blue colour indicates PCR-determined connections, red – possible 
connections and grey – excluded connections. 
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Appendix IV. 
Strain Size, Mb GC,% 
Pseudomonas aeruginosa ST395 901 5.94 66 
Pseudomonas aeruginosa ST395 950 6.55 66.1 
Pseudomonas aeruginosa 19BR 6.74 - 
Pseudomonas aeruginosa NCGM2.S1 6.76 66.1 
Pseudomonas aeruginosa LESB58 6.6 66.3 
Pseudomonas aeruginosa PAO1 6.26 66.6 
Pseudomonas aeruginosa B136-33 6.42 66.4 
Pseudomonas aeruginosa DK2 6.4 66.3 
Pseudomonas aeruginosa M18 6.33 66.5 
Pseudomonas aeruginosa PA7 6.59 66.4 
Pseudomonas aeruginosa RP73 6.34 66.5 
Pseudomonas aeruginosa UCBPP-PA14 6.54 66.3 
Chart A.4.1. Genome features various P. aeruginosa strains (according to NCBI (2)). Current 
study strain highlighted. 
 
Strain Plasmids Size, Mb GC, % 
Escherichia coli O104:H4 1218_280 3 5.41 50.6 
Escherichia coli O104:H4 str. 2011C-3493 3 5.44 50.6 
Escherichia coli O104:H4 str. 2009EL-2050 3 5.44 50.5 
Escherichia coli O104:H4 str. 2009EL-2071 2 5.39 50.7 
Escherichia coli 55989 - 5.15 50.7 
Escherichia coli O26:H11 str. 11368 4 5.86 50.7 
Escherichia coli O111:H- str. 11128 5 5.77 50.4 
Escherichia coli O157:H7 str. EC4115 2 5.7 50.4 
Escherichia coli UMNK88 5 5.67 50.7 
Escherichia coli O157:H7 str. Sakai 2 5.59 50.4 
Escherichia coli O103:H2 str. 12009 1 5.52 50.7 
Escherichia coli O55:H7 str. CB9615 1 5.45 50.5 
Escherichia coli O7:K1 str. CE10 4 5.38 50.6 
Escherichia coli ETEC H10407 4 5.33 50.7 
Escherichia coli UTI89 1 5.18 50.6 
Escherichia coli O83:H1 str. NRG 857C 1 4.89 50.7 
Escherichia coli ATCC 8739 - 4.75 50.9 
Escherichia coli IAI1 - 4.7 50.8 
Escherichia coli HS - 4.64 50.8 
Escherichia coli BL21(DE3) - 4.56 50.8 
Chart A.4.2. Genome features of different E. coli strains (according to NCBI (1)). Current study 
strain highlighted. 
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